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Abstract 
 
Blastocystis is an ubiquitous intestinal protozoon with a controversial pathogenesis and can 
colonise a wide range of species including humans, mammals, birds and reptiles. In the 
literature these species are collectively referred to as “Blastocystis”, and that will be the 
convention throughout this document as well. In humans, it has been linked with non-specific 
gastrointestinal signs, non-gastrointestinal signs such as urticaria and recently irritable bowel 
syndrome. Major hurdles to determining the clinical significance/pathogenesis of Blastocystis 
are diagnostic limitations as it is a morphologically and genetically diverse organism, poor 
understanding of host-parasite relationship and the lack of a representative model to fulfil 
Koch’s postulates. 
 
The principal aim of the project was identifying a suitable candidate for modelling human 
blastocystosis. This was defined as being a natural host of Blastocystis, meaning that the 
species had a high prevalence of Blastocystis infection with a predominant host-adapted 
subtype/s (ST) and the ability to harbour STs in common with humans. Once a candidate was 
identified, host/parasite interactions (e.g. intestinal location and pathology of Blastocystis, 
mucosal immune response) would be characterised to determine if this was comparable to the 
human infection. 
 
Dogs were identified as promising candidates as, in Brisbane, Queensland they have been 
shown to have a high Blastocystis prevalence and can harbour similar STs as in-contact 
humans. We utilised Polymerase chain reaction (PCR) to investigate the molecular 
epidemiology of Blastocystis in dogs in different geographical regions. We found a 
prevalence of 2.5%, 1.3% and 24% in dogs from Brisbane, a Cambodian village and stray 
dogs from India respectively. Stray dogs in India carried a diverse range of STs including 1, 
4, 5 and 6, while dogs from Brisbane and Cambodia only carried ST1 and ST2 respectively. 
These differences in Indian dogs compared to the Brisbane/Cambodia dogs could reflect a 
closer proximity of the dogs to humans and other animals and their faeces. We concluded that 
dogs are unlikely natural hosts for Blastocystis but rather are transiently and opportunistically 
infected with a diversity of STs. 
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Blastocystis is commonly reported in pigs, with most harbouring ST5 or ST1 and zoonotic 
transmission of ST5 from pigs has been proposed, therefore they were chosen as the next 
candidate. We studied the molecular epidemiology of pigs in two different 
geographic/environmental settings and also if they were zoonotic reservoirs by testing in-
contact humans for Blastocystis. Utilising PCR, it was found that Blastocystis prevalence in 
pigs from Southeast Queensland (SEQ) intensive piggeries and a Cambodian village was 
76.7% and 45.2%, respectively, with all positive pigs harbouring ST5. 7.1% of pigs 
harboured ST1 and/or ST3 in addition to ST5, which are the two most common STs in 
humans. A minority (13.9%) of SEQ piggery staff harboured ST5, which is otherwise rare in 
humans, indicating possible zoonotic/reverse zoonotic transmission. It appears likely that pigs 
are natural hosts of Blastocystis, presumably with ST5 as the host-adapted ST in these 
regions and can harbour similar STs to humans. For these reasons, we propose pigs as a 
promising candidate for studying human blastocystosis. 
 
To localise Blastocystis and detect any associated organic pathology in porcine intestine, light 
microscopy and PCR was used to examine faecal material, intestinal mucosal scrapings and 
histological analysis on intestinal biopsies. Intestines from 28 pigs kept under different 
management systems, namely a commercial piggery, a research facility and a small family 
farm in SEQ. All of the pigs were positive for Blastocystis ST5 and only family farm pigs had 
mixed infections with STs 1 and/or 3. Blastocystis organisms/DNA was predominantly found 
in the large intestine in all pigs, however, in research and some family farm pigs Blastocystis 
was found in the small intestine too. This raised the possibility that immunosuppression or 
environmental factors could influence Blastocystis colonisation of the small intestine which it 
otherwise might not. No obvious organic pathology was observed in the intestine histologic 
sections examined. 
 
Lastly, we attempted to characterise the Blastocystis specific faecal IgA immune response in 
the SEQ pigs utilising immunoblotting with Blastocystis antigen. We studied the response in 
pigs of different age groups (piglets, growers/weaners, sows/boars) and also five 
immunosuppressed pigs from the previous study. Majority of pigs had reactivity against 
Blastocystis proteins of molecular weights 17.5, 37, 50 and 120kDa. Interestingly, only a 
minority (18.5%) of the pigs had reactivity against a >250kDa Blastocystis protein. Piglets 
and immunosuppressed pigs were statistically more likely than the other groups to have 
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reactivity against this >250kDa protein, suggesting that immunocompromise may contribute 
to antibody production against this protein. 
 
Our results demonstrate that pigs are likely natural hosts of Blastocystis with the ability to 
harbour STs 1 and 3 that are commonly reported in humans, thus we propose them as 
promising candidates to study human blastocystosis. Blastocystis also predominantly 
colonises the porcine large intestine without causing any obvious organic pathology. We have 
raised the possibility of a link between compromised immunity and 1) the presence of 
Blastocystis in the porcine small intestine and 2) faecal IgA reactivity against a >250kDa 
Blastocystis protein. 
v 
 
Declaration by author 
This thesis is composed of my original work, and contains no material previously published 
or written by another person except where due reference has been made in the text. I have 
clearly stated the contribution by others to jointly-authored works that I have included in my 
thesis. 
 
I have clearly stated the contribution of others to my thesis as a whole, including statistical 
assistance, survey design, data analysis, significant technical procedures, professional 
editorial advice, and any other original research work used or reported in my thesis. The 
content of my thesis is the result of work I have carried out since the commencement of my 
research higher degree candidature and does not include a substantial part of work that has 
been submitted to qualify for the award of any other degree or diploma in any university or 
other tertiary institution. I have clearly stated which parts of my thesis, if any, have been 
submitted to qualify for another award. 
 
I acknowledge that an electronic copy of my thesis must be lodged with the University 
Library and, subject to the General Award Rules of The University of Queensland, 
immediately made available for research and study in accordance with the Copyright Act 
1968. 
 
I acknowledge that copyright of all material contained in my thesis resides with the copyright 
holder(s) of that material. Where appropriate I have obtained copyright permission from the 
copyright holder to reproduce material in this thesis. 
 
vi 
 
Publications during candidature 
 
Peer-reviewed papers: 
1. Wang, W., Cuttell, L., Bielefeldt-Ohmann, H., Inpankaew, T., Owen, H., Traub, R.J., 
2013. Diversity of Blastocystis subtypes in dogs in different geographical settings. 
Parasit Vectors 6, 215. 
 
2. Wang, W., Owen, H., Traub, R.J., Cuttell, L., Inpankaew, T., Bielefeldt-Ohmann, H., 
2014. Molecular epidemiology of Blastocystis in pigs and their in-contact humans in 
Southeast Queensland, Australia, and Cambodia. Vet Parasitol 203, 264-269. 
 
3. Wang, W., Bielefeldt-Ohmann, H., Traub, R.J., Cuttell, L., Owen, H., 2014. Location 
and pathogenic potential of Blastocystis in the porcine intestine. PLoS One 9, e103962. 
 
4. Wang, W., Cuttell, L., Traub, R.J., Owen, H., Bielefeldt-Ohmann, H., 2014. 
Characterisation of the Blastocystis specific faecal IgA immune response in pigs. Parasite 
Immunol, DOI: 10.1111/pim.12123. 
  
vii 
 
Publications included in this thesis 
 
This thesis includes four original published manuscripts published in peer-reviewed journals, 
they are as below: 
 
1. Wang, W., Cuttell, L., Bielefeldt-Ohmann, H., Inpankaew, T., Owen, H., Traub, R.J., 
2013. Diversity of Blastocystis subtypes in dogs in different geographical settings. Parasit 
Vectors 6, 215 – incorporated as Chapter 2 
 
Contributor Statement of contribution 
Wenqi Wang (Candidate) Designed and executed experiments (40%) 
Wrote the paper (55%) 
Sample collection (50%) 
Leigh Cuttell  Designed experiments (15%) 
Edited the paper (10%) 
Helle Bielefeldt-Ohmann  Designed experiments (10%) 
Edited the paper (10%) 
Tawin Inpankaew Edited the paper (5%) 
Sample collection (50%) 
Helen Owen  Designed experiments (10%) 
Edited the paper (10%) 
Rebecca Justine Traub  Designed experiments (25%) 
Edited the paper (10%) 
 
 
viii 
 
2. Wang, W., Owen, H., Traub, R.J., Cuttell, L., Inpankaew, T., Bielefeldt-Ohmann, H., 
2014. Molecular epidemiology of Blastocystis in pigs and their in-contact humans in 
Southeast Queensland, Australia, and Cambodia. Vet Parasitol 203, 264-269 – 
incorporated as Chapter 3 
 
Contributor Statement of contribution 
Wenqi Wang (Candidate) Designed and executed experiments (45%) 
Wrote the paper (55%) 
Sample collection (50%) 
Helen Owen Designed experiments (15%) 
Edited the paper (10%) 
Rebecca Justine Traub  Designed experiments (15%) 
Edited the paper (10%) 
Leigh Cuttell Designed experiments (10%) 
Edited the paper (10%) 
Tawin Inpankaew  Sample collection (50%) 
Edited the paper (5%) 
Helle Bielefeldt-Ohmann  Designed experiments (15%) 
Edited the paper (10%) 
 
ix 
 
3. Wang, W., Bielefeldt-Ohmann, H., Traub, R.J., Cuttell, L., Owen, H., 2014. Location 
and pathogenic potential of Blastocystis in the porcine intestine. PLoS One 9, e103962 – 
incorporated as Chapter 4 
 
Contributor Statement of contribution 
Wenqi Wang (Candidate) Designed and executed experiments (45%) 
Wrote the paper (60%) 
Helle Bielefeldt-Ohmann Designed experiments (20%) 
Edited the paper (10%) 
Rebecca Justine Traub  Designed experiments (10%) 
Edited the paper (10%) 
Leigh Cuttell Designed experiments (10%) 
Edited the paper (10%) 
Helen Owen Designed experiments (15%) 
Edited the paper (10%) 
 
 
x 
 
4. Wang, W., Cuttell, L., Traub, R.J., Owen, H., Bielefeldt-Ohmann, H., 2014. 
Characterisation of the Blastocystis specific faecal IgA immune response in pigs. Parasite 
Immunol, DOI: 10.1111/pim.12123. – incorporated as Chapter 5 
 
Contributor Statement of contribution 
Wenqi Wang (Candidate) Designed and executed experiments (45%) 
Wrote the paper (60%) 
Leigh Cuttell  Designed experiments (15%) 
Edited the paper (10%) 
Rebecca Justine Traub  Designed experiments (10%) 
Edited the paper (10%) 
Helen Owen Designed experiments (10%) 
Edited the paper (10%) 
Helle Bielefeldt-Ohmann  Designed experiments (20%) 
Edited the paper (10%) 
xi 
 
Contributions by others to the thesis  
 
No contributions by others. 
 
Statement of parts of the thesis submitted to qualify for the award of another degree 
 
None.
xii 
 
Acknowledgements 
First and foremost I would like to thank God for blessing me with this opportunity and the 
amazing people that he has put in my path to provide me with the help, support and 
encouragement that have been an integral part of me completing this project. It has been a 
great honour and inspiration working alongside and forming friendships with the people that I 
will mention below. 
 
Words cannot express my sincere gratitude to my supervisors Dr Helle Bielefeldt-Ohmann, 
Dr Helen Owen, Dr Rebecca J Traub and Dr Leigh Cuttell as without them none of this 
would be remotely possible. I want to thank them not only for opening my eyes to the world 
of research, nurturing and guiding me and putting their trust in me throughout this journey. 
Also on a personal level for always making time for me amidst their hectic schedules and 
their patience and understanding when life gets a little overwhelming. In addition I would to 
thank all the piggery and abattoir managers and staff, especially Paul Noone and Mark Bauer, 
as well as the academic and diagnostic services staff at the School of Veterinary Science for 
their technical assistance and also in sample collection. Special thanks to external researchers 
Dr Christen Rune Stensvold, Assoc Prof Kevin Tan, Miss Ng Geok Choo, Dr Kate Mounsey, 
and Dr Katja Fischer. Thank you to the UQ New Staff Research Start-up Fund and the 
Williams Peter Richard Trust Fund for their financial support for this project and also to the 
Australian Society of Parasitology for supporting me to participate in the World Association 
for the Advancement of Veterinary Parasitology Conference 2013.      
 
Last but not least, I would like to thank my beloved husband, Marvin, my family and my 
departed dog Summer, for their continual support and understanding through this challenging 
period. Not forgetting my friends in the UQ veterinary parasitology group and fellow post 
graduate students, especially Sze Fui, for their friendship, support and willingness to lend a 
listening ear. 
 
xiii 
 
Keywords 
Protozoa, Blastocystis, dog, pig, animal model, epidemiology, histopathology, immunology. 
 
Australian and New Zealand Standard Research Classifications (ANZSRC) 
ANZSRC code: 070708, Veterinary Parasitology, 50% 
ANZSRC code: 070704 Veterinary Epidemiology, 25%  
ANZSRC code: 070709 Veterinary Pathology, 25% 
 
 
 
Fields of Research (FoR) Classification 
FoR code: 0707, Veterinary Science, 100% 
 
 
xiv 
 
Table of Contents 
Abstract ................................................................................................................................. ii 
Declaration by author .......................................................................................................... v 
Publications during candidature ....................................................................................... vi 
Publications included in this thesis ................................................................................... vii 
Contributions by others to the thesis ................................................................................ xi 
Statement of parts of the thesis submitted to qualify for the award of another degree
........................................................................................................................................... …xi 
Keywords ........................................................................................................................... xiii 
Australian and New Zealand Standard Research Classifications (ANZSRC) ............ xiii 
Fields of Research (FoR) Classification .......................................................................... xiii 
Chapter 1: Literature Review & Hypotheses .................................................................... 1 
1.1 Background ................................................................................................................. 2 
1.2 Morphology ................................................................................................................. 2 
1.3 Life cycle / Transmission ............................................................................................ 5 
1.4 Subtypes ...................................................................................................................... 6 
1.5 Epidemiology in humans ............................................................................................. 8 
1.6 Diagnosis ..................................................................................................................... 9 
1.7 Clinical presentation of blastocystosis ...................................................................... 11 
1.8 Irritable Bowel Syndrome (IBS) and its relation to blastocystosis ........................... 11 
1.9 Treatment .................................................................................................................. 12 
1.10 Pathogenicity / clinical significance ........................................................................ 13 
1.10.1 Pathogenicity – phenotype / intensity of infection .......................................... 13 
1.10.2 Pathogenicity – genotype / ST ......................................................................... 14 
1.10.3 Pathogenicity – histopathology ....................................................................... 14 
1.10.4 Pathogenicity – in vitro studies ....................................................................... 15 
1.10.5 Pathogenicity – Immunology .......................................................................... 16 
xv 
 
1.11 Animal Infectivity Models ...................................................................................... 17 
      1.12  Hypotheses and aims...............................................................................................18 
Chapter 2:  Diversity of Blastocystis subtypes in dogs in different geographical settings
.............................................................................................................................................. 20 
2.1 Manuscript Information ............................................................................................ 21 
Chapter 3: Molecular epidemiology of Blastocystis in pigs and their in-contact humans 
in Southeast Queensland, Australia, and Cambodia ...................................................... 22 
3.1 Manuscript Information ............................................................................................ 23 
Chapter 4: Location and pathogenic potential of Blastocystis in the porcine intestine…
.............................................................................................................................................. 24 
4.1 Manuscript Information ............................................................................................ 25 
Chapter 5: Characterisation of the Blastocystis specific faecal IgA immune response in 
pigs ....................................................................................................................................... 26 
5.1 Manuscript Information ............................................................................................ 27 
Chapter 6: Discussion and conclusions ............................................................................ 28 
6.1 Introduction ............................................................................................................... 29 
 6.1.1  Pigs models to study human disease..............................................................29 
6.2 Hypotheses, aims and main findings ......................................................................... 30 
6.3 Strengths and limitations of the study ....................................................................... 33 
6.4 Future directions ........................................................................................................ 35 
6.4.1 Utilising multilocus sequence typing (MLST) to study the transmission   
dynamics of STs 1, 3 and 5 between pigs and humans. ............................................. 35 
6.4.2  ...... Obtaining axenic cultures from pigs and/or symptomatic humans for animal 
infectivity studies and in vitro studies ........................................................................ 36 
6.4.2.1 In vitro studies ................................................................................................ 36 
6.4.2.2 Experimental infections .................................................................................. 36 
6.5 Conclusions ............................................................................................................. 377 
Chapter 7: References ....................................................................................................... 38 
 
xvi 
 
 
 
List of Figures: 
Figure 1  Morphological forms of Blastocystis by phase contrast microscopy ..................... 3 
Figure 2  Proposed life cycle for Blastocystis  ....................................................................... 5 
 
List of Tables: 
Table 1  Blastocystis ST distribution in humans and various animals ................................... 7 
xvii 
 
Abbreviations 
 
µm – Micrometer 
99mTc labelled DTPA - Diethyl triamine penta acetic acid labelled with 99m Technetium 
assay 
bp – Base pair 
DNA - Deoxyribonucleic acid 
ELISA – Enzyme-linked immunosorbent assay 
FECT – Formol-ether concentration technique 
GM-CSF – Granulocyte-macrophage colony stimulating factor 
HIV – Human immunodeficiency virus 
IBS – Irritable Bowel Syndrome 
IFA – Immunofluorescence assay 
IgA – Immunoglobulin A 
IgG – Immunoglobulin G 
IgM – Immunoglobulin M 
IL – Interleukin 
kDa – Kilo Dalton 
MLO – Mitochondrion-like organelle 
MLST – Multilocus sequence typing 
NHPs – Non-human primates 
nm – Nanometre 
PCR – Polymerase chain reaction 
qPCR – Quantitative real time PCR 
RNA – Ribonucleic acid 
SEQ – Southeast Queensland 
SSU rDNA - Small subunit ribosomal DNA 
xviii 
 
SSU-rRNA - Small subunit ribosomal RNA 
ST – Subtype 
STS – Subtype-specific 
XIVC – Xenic in vitro culture 
1 
 
 
Chapter 1:                                 
Literature Review 
 
 
2 
 
1.1 Background 
Blastocystis is a unicellular, anaerobic, enteric protozoan parasite of humans, dogs and many other 
animals. The classification of Blastocystis has been a long and controversial task due to the 
polymorphic morphology, extensive genetic diversity and lack of standardisation of diagnostic 
techniques (Tan, 2008). Blastocystis was first definitively described in 1911 by A.Alexieff as an 
enteric yeast (reviewed in Zierdt, 1991). Subsequently, the protozoan characteristics of Blastocystis 
were first described by Zierdt in 1976 and since then it has been re-classified as a protozoan (Zierdt, 
1991). Continuing studies have been carried out to characterise Blastocystis more accurately. The 
current classification system is: as a protozoa, Blastocystis is non-motile, does not possess a flagella 
and is classified as follows: Eukaryota > Stramennopiles > Genus: Blastocystis > Species: 
Blastocystis (Tan et al., 2010). 
 
1.2 Morphology 
The morphology of Blastocystis is not well understood and many different forms have been 
described in the literature. Currently, the general consensus is that there are four main morphologic 
forms of Blastocystis, namely the vacuolar, granular, amoeboid and cystic forms (Tan, 2008) 
(Figure 1). 
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Figure 1 Morphological forms of Blastocystis by phase contrast microscopy (modified from 
(Tan, 2008)). (A) Vacuolar forms, (B) Granular forms, (C) Amoeboid forms and (D) Cyst 
forms. Bar 10 ɥm. 
 
Vacuolar form: The vacuolar and granular forms are the two most commonly observed forms of 
Blastocystis. The vacuolar form is usually observed in laboratory culture and faecal samples 
(Stenzel and Boreham, 1996; Tan, 2008). It is spherical and is often surrounded by a 
capsule/surface coat/fibrillar layer and contains a single, large, vacuole that is concentric with the 
outer membrane. This vacuole can constitute up to 90% of cell volume, displacing the cytoplasm 
and organelles to the periphery (Tan, 2008; Zierdt, 1991). The cytoplasmic organelles include 
nuclei, Golgi apparatus and mitochondria-like structures. This form is often multinucleated and can 
have up to 4 nuclei (Tan, 2008).  Its size ranges from 2 to 200µm diameter, with an average of 4 to 
15 µm (Tan, 2008; Zierdt, 1991).  
 
Granular form: The granular form is similar in appearance and ultrastructure to the vacuolar form 
except that it contains intra-vacuolar or intra-cytoplasmic, heterogeneous granules (Stenzel and 
Boreham, 1996; Tan, 2008) and cytochemically different vacuole contents. It is usually observed in 
non-axenised, mature or antibiotic treated cultures (Stenzel and Boreham, 1996; Tan, 2008) and it 
has been hypothesised that the vacuolar form can be induced to convert to the granular form under 
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these culture conditions (Stenzel and Boreham, 1996). These forms are usually slightly larger than 
the average vacuolar forms, ranging from approximately 10-60µm in diameter on average (Stenzel 
and Boreham, 1996). 
 
Amoeboid form: The amoeboid form is a rare and poorly understood form of Blastocystis, with 
numerous conflicting descriptions. They have been observed in faecal samples, old or drug-treated 
cultures and colonies grown in soft agar (Tan, 2004, 2008). Corroborating reports describe the 
presence of one or more large pseudopod-like cytoplasmic extensions and intracytoplasmic 
liposomal-like compartments containing bacterial remnants (suggestive of a phagocytic and/or 
nutritional role of this form) (Stenzel and Boreham, 1996; Tan, 2004, 2008). Size ranges that have 
been reported include 2.6 to 15µm in diameter (Stenzel and Boreham, 1996; Tan, 2008). Tan & 
Suresh (Tan and Suresh, 2006) reported a predominance of amoeboid forms in symptomatic 
compared to asymptomatic patients, suggesting that they could be pathogenic forms.  
 
Cyst form: The cyst form is the most environmentally resistant form of Blastocystis and is most 
commonly observed in faecal samples (especially several day old samples) (Stenzel and Boreham, 
1996).  It is ovoid to round and is the smallest form, measuring approximately 2-6µm in diameter. It 
is surrounded by a multi-layered cyst wall that is found just under the surface coat, measuring 50 to 
100nm and can have up to 4 nuclei as well (Moe et al., 1997; Tan, 2004; Zaman et al., 1997). 
Studies have shown that the cyst is resistant to gastric secretions and is likely to be the transmissible 
form of Blastocystis via the faecal-oral route (Moe et al., 1997; Yoshikawa et al., 2004c).  
 
Given the poor understanding of Blastocystis morphology and life cycle, there is a possibility that 
any of the four main or previously described forms of Blastocystis may be artefactual or in vitro 
forms of Blastocystis (Clark et al., 2013). Considering that Blastocystis can be morphologically 
indistinguishable from yeast, Cyclospora sp. or fat globules in a direct faecal smear, it is a relatively 
subjective and difficult task to assign each cell a form (Tan, 2008). Furthermore, this has or could 
cause discrepancies between various ultrastructural studies as the majority has been performed on 
Blastocystis cultured forms as well as in epidemiological studies if light microscopy was the sole 
diagnostic technique used. Future studies should aim to investigate the alterations in cellular 
physiology and biochemistry of in vitro cultures before determining if the in vitro data can be 
applied to in vivo forms. 
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1.3 Life cycle / Transmission 
The life cycle of Blastocystis is poorly understood with numerous studies having proposed various 
contradictory life cycles and reproductive modes.  Currently, the only accepted mode of 
reproduction is binary fission of the vacuolar and granular forms, where these forms have been 
observed to divide into two approximately equal portions together with the organelles (Stenzel and 
Boreham, 1996; Tan, 2008). Other proposed reproductive modes include multiple fission, 
schizogony, plasmotomy (budding) and endodyogeny, however, there is still insufficient supportive 
evidence for any of these (Tan, 2008). The most accepted mode of transmission is the faecal-oral 
route and Figure 2 shows a proposed life cycle for Blastocystis (modified from Tan, 2008). 
 
Figure 2 Proposed life cycle for Blastocystis (modified from Tan, 2008).  
Humans and animals are infected by ingestion of faecal cysts, which develop into vacuolar forms in 
the large intestines. In humans, vacuolar forms divide by binary fission and may develop into 
amoeboid or granular forms. Vacuolar forms undergo encystation in the host intestines, and 
intermediate cyst forms may be surrounded by a thick fibrillar layer that is subsequently lost during 
passage in the external environment. Information on the transition from the amoeboid to the 
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vacuolar form and from the vacuolar to the cyst form is lacking. These hypothetical pathways are 
represented by dotted lines in Figure 2. The proposed scheme suggests that humans are potentially 
infected by many subtypes (STs) of Blastocystis and that certain animals represent zoonotic 
reservoirs for transmission to humans (modified from Tan, 2008). 
 
At present, the most accepted proposed mode of transmission is the faecal-oral route either by  
direct contact or water-borne transmission (through cysts) even though few controlled studies have 
been done (Lee et al., 2012; Leelayoova et al., 2008). Reported predisposing factors for Blastocystis 
infections in humans include immunocompromise (e.g. children, human immunodeficiency virus 
(HIV) infection, immunosuppresive therapy), regular animal exposure, travel to tropical or 
developing areas and poor hygiene (Tan, 2008) .  
 
In a rural Nepalese community, Lee et al. (Lee et al., 2012) found an unusually high prevalence of 
ST4 infection in humans and their livestock (buffaloes and pigs) as well as in the rivers they 
frequent. Similarly, an unexpectedly high prevalence (25%) of ST8 was observed in primate 
handlers, which is normally a very rare ST in humans but found in the in-contact non-human 
primates (NHPs). These results suggest that zoonotic, direct and/or waterborne transmission of 
Blastocystis occurs. 
 
1.4 Subtypes 
Molecular analysis of the 18S small subunit ribosomal RNA (SSU-rRNA) gene has allowed for 
subdivision of Blastocystis into 17 different STs and these can be found in humans and a wide range 
of animals (NHPs, mammals, birds, reptiles)  worldwide (Alfellani et al., 2013c; Stensvold et al., 
2009a; Stensvold et al., 2007b) (Table 1). STs are characterised by having at least 5% genetic 
divergence (Clark et al., 2013; Stensvold, 2013a) in the SSU rDNA sequences.  
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ST 1 +++ ++ / +++ + /   
ST 2 ++ ++ / /  /   
ST 3 ++++ ++  / +    
ST 4 ++ / /    +  
ST 5 / + / +++ ++    
ST 6 /  /   +   
ST 7 /     +   
ST 8 / +   / /   
ST 9 /        
ST 10  /   ++    
ST 11        elephants 
/ ST 12       / giraffes 
ST 13  /     /  
ST 14     /    
ST 15  /   /    
ST 16       /  
ST 17       /  
 
Table 1  Blastocystis ST distribution in humans and various animals (Alfellani et al., 2013a; 
Alfellani et al., 2013b; Alfellani et al., 2013c; Stensvold et al., 2009a; Tan et al., 2010; Wang et al., 
2013; Wang et al., 2014c). NHP - non-human primates; (blank) - not reported 
Key    +++ - very frequently isolated        
 ++ - frequently isolated 
 + - occasionally isolated 
 /     - rarely isolated          
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The current available data on ST distribution in different host species (Table 1) shows that each ST 
is unique in the number and type of host species that it infects, therefore suggesting that 1) each ST 
has mild to moderate host specificity (Stensvold et al., 2009a; Tan, 2004) and that certain species 
(e.g. pigs, chickens, NHPs) could potentially be potential reservoirs for zoonotic and/or interspecies 
transmission (Tan, 2004). An example is ST1 which has moderate host specificity and is commonly 
found in humans, NHPs and pigs whereas ST6/7 has high host specificity and is predominantly 
found in birds or rather are considered “avian STs”. Undoubtedly, more STs remain to be 
discovered and more hosts to be tested to further contribute to this data and provide a clearer picture 
of host specificity (Clark et al., 2013). 
 
1.5 Epidemiology in humans 
Blastocystis is an extremely common protozoa in humans with or without gastrointestinal 
symptoms in various countries (Amin, 2002, 2006; Clark, 2000; Windsor et al., 2002). There is a 
high prevalence worldwide with published rates from 0.5% in Japan and 23% in USA, to 60% in 
Indonesia (Amin, 2002, 2006; Tan, 2008). However it is likely that the majority of these study 
results are skewed as often either 1) the sampling is highly selective (e.g. children, symptomatic 
patients) 2) the sample is small and/or 3) the diagnostic method used is not ideal (e.g. light 
microscopy only) (Clark et al., 2013; Stensvold et al., 2009c).  
 
Humans have been shown to harbor STs 1 to 9 (Table 1) and recently these STs in humans were 
shown to have variable geographical distribution worldwide (Alfellani et al., 2013b). In that study, 
STs 1 and 3 followed by STs 2 and 4 were the most frequently identified STs in humans worldwide, 
accounting for more than 90% of human infections, with variation of predominant ST/s between 
populations and subpopulations (Alfellani et al., 2013b). An example is ST4, this is the second most 
common ST detected in humans in the UK and is found throughout Europe however is much less 
often reported/absent in Asia, South America and North America (Alfellani et al., 2013b). 
 
Intra-ST genetic variation of up to 3% has been demonstrated within certain STs following 
comparison of SSU rDNA sequences (Alfellani et al., 2013c; Clark et al., 2013; Stensvold et al., 
2012b; Yoshikawa et al., 2009). A multilocus sequence typing (MLST) scheme was generated for 
ST3 and ST4 by first aligning mitochondrion-like organelle (MLO) genomes of chosen ST3 and 
ST4 isolates respectively, then locating seven loci with clustered nucleotide differences 
(polymorphism) between the isolates (Stensvold et al., 2012b). Using this scheme, they 
demonstrated significant differences within ST3 and ST4 by comparison of multilocus sequence 
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typing (MLST) data from 132 samples (with STs 3 or 4) and complete / partial SSU rDNA 
sequences.  The greater intra-ST genetic variability of ST3 suggests that it has colonised humans for 
longer than ST4 and therefore has had more time expand in humans (Stensvold et al., 2012b). 
Future studies using more high resolution molecular markers (e.g. to investigate intra-ST variation) 
might provide further insights into epidemiology, host specificity and pathogenicity of Blastocystis. 
 
1.6 Diagnosis 
The standard methods of Blastocystis detection are a direct faecal wet smear, permanent stained 
smears (e.g. trichrome), formol-ether concentration technique (FECT), xenic in vitro culture 
(XIVC) and polymerase chain reaction (PCR). Laboratory diagnosis of Blastocystis is difficult and 
controversial at times, whether using microscopic or molecular methods, due to the polymorphic 
morphology, poorly understood life cycle and also the significant inter-ST and intra-ST genetic 
diversity (Alfellani et al., 2013a; Stensvold et al., 2012b; Tan, 2008). 
 
Human diagnostic laboratories routinely use light microscopy (direct or stained faecal smear) rather 
than PCR for Blastocystis diagnosis, as it is cheaper to operate, and this could lead to under / 
misdiagnosis as its morphology varies greatly (Tan, 2008). A comparison of 5 reference human 
laboratories’ diagnosis of various intestinal helminths and protozoa using FECT demonstrated 
poorer agreement for Blastocystis relative to other parasites (Utzinger et al., 2010). Studies have 
collectively demonstrated that XIVC is more sensitive than a direct or stained faecal smear and the 
FECT technique and its sensitivity is almost comparable to PCR, which is by far the gold standard 
(Leelayoova et al., 2002; Stensvold et al., 2007a; Stensvold et al., 2006). However, unlike PCR, 
XIVC does not allow for subtyping of Blastocystis, therefore would only be recommended as an 
alternative cost-effective method to be used in diagnostic laboratories (Stensvold et al., 2007a). It 
has also been recognised that there is intermittent shedding of Blastocystis in faeces, therefore 
collection of more than one sample is highly recommended, especially in clinical cases (Stensvold 
et al., 2009c; Tan et al., 2010). 
 
PCR is the gold standard for Blastocystis detection and subtyping and can be performed on faecal or 
culture material (Stensvold et al., 2007b; Stensvold et al., 2006; Tan et al., 2010). Blastocystis is 
typically subtyped using either sequence analysis of the SSU rDNA PCR products or using PCR 
ST-specific sequence tagged-site (STS) primers without sequencing (Stensvold, 2013b; Yoshikawa 
et al., 2004b). Many regions of the SSU rDNA have been amplified, however, the most commonly 
used is the 600 bp “bar code region” (Scicluna et al., 2006; Stensvold, 2013b). STS primers were 
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designed by Yoshikawa et al. (2003; 2004b) from random amplified polymorphic DNA sequences 
of Blastocystis and currently STS 1 to 7 primers are available. These are particularly useful in 
identifying and characterising mixed ST infections. A comparative study of these two techniques 
demonstrated that “bar code region” SSU rDNA-based subtyping has better applicability and higher 
sensitivity than STS primers (Stensvold, 2013b). Subtyping as part of Blastocystis diagnosis is of 
importance as the data can be used to check for epidemiological association between STs and 
clinical associations such as outcome or pathogenicity (Stensvold, 2013b). The theory of ST 
dependent pathogenicity has been raised by several studies in recent years (Jones et al., 2009; 
Stensvold et al., 2008; Stensvold et al., 2011; Stensvold et al., 2009b; Vogelberg et al., 2010) with 
certain STs such as STs 1, 2, 3, 4 or 8 often being associated with gastrointestinal symptoms, details 
will be discussed under the Pathogenicity section. 
 
Three real-time PCR assays specific to Blastocystis have been developed and are more sensitive 
than conventional PCR (Jones et al., 2008; Poirier et al., 2011; Stensvold et al., 2012a). Two out of 
the three assays are quantitative real time PCRs (qPCR) designed from SSU rDNA gene sequences 
that allow for determination of intensity of infection (Poirier et al., 2011; Stensvold et al., 2012a), 
whilst the third assay amplifies an uncharacterised Blastocystis genome region and does not allow 
for quantification. The qPCR designed by Stensvold et al. (2012a) uses probe based detection as 
compared to the other two assays that use SYBR Green, therefore has a higher sensitivity and 
specificity with no false positives reported. This  qPCR (Stensvold et al., 2012a) still recommends 
that positive samples be subtyped based on the 600 bp “bar code region” (Scicluna et al., 2006) that 
is very well characterised, whilst the Poirier et al. (2011) assay recommends subtyping directly from 
the 320-342 bp qPCR sequence. 
 
Recently, Savyon Diagnostics developed an immunofluorescence (IFA) and a direct enzyme-linked 
immunosorbent assay (ELISA) to detect Blastocystis antigen in human faecal samples. The ELISA 
was tested in two laboratories and had a sensitivity of 94.7%- 96.1% and specificity of 96.1 - 100% 
for fresh and sodium acetate-acetic acid fixed stool samples respectively, while the IFA had 86.7% 
sensitivity. Both experiments used XIVC as a standard (Dogruman-Al et al., 2010). More 
comparison studies need to be done to evaluate these new assays. To aid with future Blastocystis 
research, it is highly recommended that there is a standardization of diagnostic methods for 
Blastocystis which includes routine subtyping of Blastocystis, as it would help to improve our 
understanding of clinical significance (ST-dependent pathogenicity), epidemiology and 
transmission of Blastocystis.  
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1.7 Clinical presentation of blastocystosis  
Blastocystosis is defined as infection with Blastocystis. Clinical signs are variable and range from 
gastrointestinal signs such as diarrhoea, abdominal pain, cramps, flatulence, nausea, vomiting, 
constipation, weight loss and anorexia to extra-gastrointestinal signs such as skin rashes or urticaria, 
palmoplantar pruritis and infective arthritis (Katsarou-Katsari et al., 2008; Mahmoud and Saleh, 
2003; Nasirudeen and Tan, 2004; Stensvold et al., 2009b; Tan, 2008; Tan et al., 2010; Zierdt, 
1991). There has been speculation that the extra-gastrointestinal signs are either truly linked to 
blastocystosis or might be immune mediated, however, the mechanisms are unknown (Stensvold et 
al., 2009c; Tan et al., 2010). Diarrhoea and abdominal pain are the two most common clinical signs 
(Mahmoud and Saleh, 2003; Tan, 2008; Tan et al., 2010). Infection in immunocompetent, 
symptomatic patients is usually self-limiting over a period of a few days (Mahmoud and Saleh, 
2003; Zierdt, 1991; Zierdt et al., 1995). 
 
1.8 Irritable Bowel Syndrome (IBS) and its relation to blastocystosis 
The Gastroenterological Society of Australia defines IBS as a chronic relapsing disorder of 
gastrointestinal function, the main features of which are abdominal pain associated with an altered 
bowel habit, in the absence of any structural pathology. There are three main subgroups, namely 
patients with constipation or diarrhea predominantly or alternating diarrhea and constipation. The 
reported prevalence of IBS in the western world ranges from 10-20% (Hungin et al., 2005; Posserud 
et al., 2006; Wilson et al., 2004) and it is of socioeconomic importance in these countries. IBS 
sufferers appeared to take more days off work, were less productive and active (Hungin et al., 2005) 
and overall it was estimated that it was costing the United States of America and the United 
Kingdom between US$348 - 8750 and US$355 - 3344 per IBS patient, respectively (Maxion-
Bergemann et al., 2006).  
 
IBS is a complex multifactorial syndrome and its pathophysiology still remains elusive. Factors that 
may contribute to its development include visceral hypersensitivity, abnormal gastrointestinal 
motility, gut flora alteration, post-infectious IBS, genetic predisposition and psychosocial factors 
(Karantanos et al., 2010; Ohman and Simren, 2007; Posserud et al., 2006). There has been 
increasing evidence suggesting that low grade transient or chronic inflammation, immunological 
alterations, or increased epithelial permeability in the intestinal mucosa may be of significance in 
certain subgroups of IBS patients (Collins et al., 2001; Ohman and Simren, 2007, 2010; Piche et al., 
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2009) . These studies have estimated that 3.7 - 36% of patients develop IBS after an episode of 
infectious diarrhoea (Abrahamsson et al., 2008; Ohman and Simren, 2007, 2010; Parry et al., 2003). 
 
In the past decade, there has been an increase in literature associating blastocystosis and IBS. The 
two key reasons being that there appears to be a higher infection rate with Blastocystis in IBS as 
compared to non-IBS patient controls and that both disorders cause similar nonspecific 
gastrointestinal signs (Boorom et al., 2008; Giacometti et al., 1999; Stark et al., 2007; Yakoob et al., 
2004). In contrast, there have also been studies that have failed to show this association (Ramirez-
Miranda et al., 2010; Tungtrongchitr et al., 2004). 
 
A proposed mechanism linking IBS to blastocystosis is the low grade transient/chronic intestinal 
mucosal inflammation (which is recognised in subgroups of IBS patients) that has been observed in 
blastocystosis in experimental animals (Elwakil and Hewedi, 2010; Moe et al., 1997; Phillips and 
Zierdt, 1976). Another mechanism could be direct immune activation as demonstrated by Hussain 
et al. (Hussain et al., 1997), these authors found increased Blastocystis specific IgG and IgG2 levels 
in IBS patients compared to asymptomatic controls. Alternatively, immune activation could be 
secondary to blastocystosis associated intestinal epithelial disruption observed in human intestine 
(Dagci et al., 2002) and in vitro studies (Mirza et al., 2012; Puthia et al., 2006). Bearing in mind that 
a disrupted intestinal environment (e.g. IBS) could always encourage the organism to thrive, it is 
possible that Blastocystis may not be the cause of IBS and more extensive controlled studies with 
proper controls, larger sample size, standardised diagnostic methods (including subtyping) and 
thorough exclusion of other aetiologies need to be conducted to clearly define its role, if any, in 
intestinal disease and IBS (Stark et al., 2007; Tan, 2008).   
 
1.9 Treatment 
Given the controversial pathogenicity of Blastocystis as well as the self-limiting nature of the 
infection, treatment for blastocystosis is routinely administered only in symptomatic patients only 
when all other aetiologies have been excluded. Metronidazole is the mainstay of treatment for 
human intestinal protozoa and the first-line therapy for blastocystosis where therapy is required 
(Coyle et al., 2012; Sekar and Shanthi, 2013; Stensvold et al., 2010; Tan, 2004; Tan et al., 2010). 
Efficacy studies on metronidazole therapy  report 0-100% efficacy (Stensvold et al., 2010) while in 
vitro studies have shown either resistance  in certain STs/isolates or cyst forms (Mirza et al., 2011; 
Zaman and Zaki, 1996) or that metronidazole can indirectly induce programmed cell death in 
Blastocystis (Puthia et al., 2008; Puthia et al., 2006). 
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A common alternative drug is trimethoprim sulfamethoxazole and similarly there have been 
conflicting efficacy results with this antimicrobial (Moghaddam et al., 2005; Ok et al., 1999; 
Stensvold et al., 2008). Other treatment options for blastocystosis include antimicrobials such as, 
nitazoxanide, furazolidone and emetine, ketoconazole, tinidazole and even the probiotic 
Saccharomyces boulardii (Sekar and Shanthi, 2013; Stensvold et al., 2010; Tan et al., 2010). To 
date there is little experimental data to verify the efficacy of the other drugs used for blastocystosis 
treatment either.  
 
In addition, it is important that diagnostic methods are standardised (ideally PCR with subtyping) in 
future drug efficacy studies in order to ensure that patients are still infected with the same ST (as 
opposed to being infected with a new ST during the course of the study) at the end of the treatment 
and also to provide information to determine ST-dependent pathogenicity. Chemotherapeutic 
intervention of blastocystosis is complicated, with multiple host and parasite factors to consider 
such as appropriate drug selection, dose schedule, mechanism of action, drug resistance, infection 
density, ST / strain dependent drug susceptibility and so on (Stensvold et al., 2010). Most 
importantly, until the pathogenicity of Blastocystis has been determined it is difficult to determine 
the most appropriate therapy.  
 
1.10 Pathogenicity / clinical significance 
Up till now, the clinical significance / pathogenicity of Blastocystis are debatable and there are still 
many aspects of the infection to be established. The key reasons as to why preceding studies have 
failed to produce unanimous results are: 1) poor understanding of the biology and host-parasite 
relationship, 2) use of non-standardised diagnostic techniques 3) not interpreting data in light of 
Blastocystis genotype / ST, 4) polymorphic nature and extensive genetic diversity of the 
Blastocystis, 5) small study population and sample sizes, 6) lack of proper controls and 7) failure to 
exclude all other possible origins of symptoms  (Clark et al., 2013; Stensvold et al., 2009c; Tan et 
al., 2010). There has been a myriad of clinical, epidemiological and molecular studies that have 
implicated Blastocystis as a potential pathogen based on various approaches, oftentimes with 
contradicting results, these will be further discussed.  
 
1.10.1 Pathogenicity – phenotype / intensity of infection 
In terms of phenotype dependent pathogenicity of Blastocystis, one study found a predominance of 
irregular amoeboid forms of Blastocystis in all cultured isolates from 10 symptomatic patients as 
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compared to none in 10 asymptomatic controls, suggesting that this form could be an indicator of 
pathogenic Blastocystis isolates (Tan and Suresh, 2006). The literature has also raised the link 
between intensity of infection and symptoms, however, results have been inconsistent (Tan, 2008). 
The intensity of infection in these studies have been measured using light microscopy (wet or 
permanent stained faecal smears) which is highly operator dependent and potentially subjective 
(Tan, 2008). Therefore, if future studies were to try to quantify Blastocystis infection, a more 
objective and sensitive technique to use would be qPCR assays which have been developed as 
reviewed above (Clark et al., 2013; Poirier et al., 2011; Stensvold et al., 2012a).  
 
1.10.2 Pathogenicity – genotype / ST 
In recent years large amounts of genetic data on Blastocystis has been generated that has 
demonstrated significant inter-ST and even intra-ST genetic diversity and with this came the 
hypothesis of genotype / ST-dependent pathogenicity. ST4 has been linked with acute diarrhoea in 
Danish patients (Stensvold et al., 2011) and acute and chronic diarrhoea in Valencia, Spain 
(Dominguez-Marquez et al., 2009). ST 2 has been associated with bloating (Stensvold et al., 2009b) 
and an isolated case of chronic, recurring gastrointestinal illness and urticaria (Vogelberg et al., 
2010). ST3 has been linked to chronic gastrointestinal illness in Oregon (Jones et al., 2009) and 
acute urticaria coupled with mild gastrointestinal illness in an isolated case (Katsarou-Katsari et al., 
2008). In contrast, there are several studies that found ST3 in asymptomatic human isolates 
(Stensvold et al., 2007a; Yan et al., 2007; Yoshikawa et al., 2004a). Results have been far from 
conclusive, often with isolated cases, small scale studies, different diagnostic techniques (STS 
versus sequencing), no appropriate controls or failure of exclusion of other causes. Emerging data 
on geographical distribution of STs and intra-ST genetic diversity may shed light on discrepancies 
between previous studies and also should be considered and incorporated into future studies. 
 
1.10.3 Pathogenicity – histopathology 
In terms of histopathology, no human studies have demonstrated any conclusive histopathology 
associated with Blastocystis infection. A study by Dagci (2002) did not note any histopathology in 
human intestinal biopsies from patients who were positive for Blastocystis, however did report 
potential increase in intestinal permeability using the diethyl triamine penta acetic acid labelled with 
99m Technetium (99mTc labelled DTPA) assay.  
 
Reported histopathological findings in animal infectivity studies include minimal to severe 
inflammation, mucosal sloughing, mild lamina propria oedema and Blastocystis organisms in 
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luminal material, at the epithelial edge or invading the epithelium in the caecum / colon (Iguchi et 
al., 2007; Moe et al., 1997; Phillips and Zierdt, 1976; Tan, 2008; Yoshikawa et al., 2004c). There 
are only two out of numerous studies (Elwakil and Hewedi, 2010; Phillips and Zierdt, 1976) that 
have cited Blastocystis organisms invading the intestinal mucosa; however, this issue is still highly 
debated. Regardless of their ability to invade the intestine, their pathogenic potential cannot be 
dismissed. There is increasing evidence that pathogens do not need to invade the intestinal 
epithelium to be pathogenic, there are innumerable signaling pathways that could result in radical 
physiological changes (e.g. inflammation, apoptosis) that would result in clinical signs (Berkes et 
al., 2003) and some of these are discussed in the following section. 
 
1.10.4 Pathogenicity – in vitro studies  
Many of the in vitro pathogenicity studies focus on investigating the effect of blastocystosis on host 
defense mechanisms (i.e. host mucosal immunomodulation and disruption of intestinal epithelium 
function / permeability) and Blastocystis potential survival and propagation mechanisms.  
 
Cysteine proteases are enzymes that catalyse hydrolysis of amide protein bonds and have been 
shown to be involved in “housekeeping” tasks of many protozoa (e.g. Giardia, Entamoeba 
histolytica, Cryptosporidium) but also in processes such as host cell invasion, stimulation / evasion 
of host immune response, parasite development, differentiation and virulence factors among others 
(Klemba and Goldberg, 2002). Significant amounts of cysteine proteinases have been demonstrable 
within the central vacuole of Blastocystis ratti (Isolate WR1, ST4) (Puthia et al., 2008). In that 
study, they also showed that WR1 cysteine proteases were able to modulate the immune response 
by indirectly activating the proinflammatory cytokine interleukin – 8 (IL-8) gene expression in 
human colonic epithelial cells in a time-dependent manner.  Two other studies showed similar 
results, where they noticed a significant increase in pro-inflammatory cytokines IL-8, IL-6, and/or 
granulocyte-macrophage colony stimulating factor (GM-CSF) following Blastocystis incubation 
with colonic/colorectal epithelial cells lines HT-29, T84 and HCT 116 respectively, suggestive of a 
Blastocystis triggered intestinal inflammatory response (Chandramathi et al., 2010a; Long et al., 
2001). In addition, Blastocystis proteases (predominantly cysteine and aspartic proteases) were 
shown to degrade human secretory IgA (Puthia et al., 2005), which will promote mucosal adhesions 
and survival of Blastocystis organisms in the intestine. 
 
With regards to disruption of intestinal epithelial integrity / function, cysteine proteases were also 
suggested to be able to induce rho-kinase dependent disruption of the intestinal epithelial function 
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by reorganization of cytoskeleton F-actin and tight junction zona occludens-1 (Mirza et al., 2012). 
Similarly, co-incubation of Blastocystis and IEC – 6 cell monolayers also caused a significantly 
higher percentage of microfilament F-actin rearrangement, resulting in a significant decrease in 
transepithelial resistance and increased epithelial permeability. In an in vivo study by Dagci et al. 
(2002) similar results were observed where there was significantly increased intestinal permeability 
(measured using 99mTc labeled DTPA assay) in Blastocystis infected patients as compared to 
controls. 
  
Lastly, Blastocystis incubation with IEC-6 and HCT-116 cells have been shown to induce contact 
apoptosis of IEC-6 cells (rat intestinal cell line) (Puthia et al., 2006) and also apoptosis of peripheral 
blood mononuclear cells when incubated with HCT-116 cells (Chandramathi et al., 2010a). The 
majority of the in vitro studies rely on the few axenised isolates of Blastocystis that are currently 
available as unsuccessful axenisation of Blastocystis has been an ongoing problem in many 
laboratories. Many of these isolates have been cultured in vitro for long periods of time and 
structural and/or functional changes (e.g. decreased virulence) may have occurred. This is one of 
the major hurdles in development of an animal model, the difficulty in axenising suitable, suspected 
pathogenic Blastocystis isolates from symptomatic patients. 
 
1.10.5 Pathogenicity – Immunology 
In comparison, fewer serological studies of Blastocystis have been conducted and there has been 
little agreement between them. Zierdt et al. (1995) reported a Blastocystis specific IgG serum 
response in 25/28 symptomatic humans, but an IgA response was not observed. On the other hand, 
Mahmoud & Saleh (2003) showed significantly higher levels of anti-Blastocystis IgA and IgG fecal 
and serum antibodies and Blastocystis antigen levels in symptomatic patients than in asymptomatic 
patients. Santos & Rivera (2009) characterised the immune response in serum and intestinal 
secretions of Blastocystis immunised Balb/C mice over an eight week period and they found that 
IgM levels were high in the early stages in serum while IgA was the predominant antibody in the 
intestinal secretions. It seems that IgA may play an important role in the immune response against 
Blastocystis. 
  
Hegazy et al. (2008) found that there were only minor differences in the 30kDa, 50 kDa and 118 
kDa molecular weight proteins in the protein profile of Blastocystis isolates obtained from children 
with gastroenteritis or those that were clinically healthy, with two other studies showing similar 
results (Chen et al., 1999; Tan et al., 1996).  In contrast, Gamra et al. (2010) found that a 
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significantly higher number of symptomatic patients had an anti-Blastocystis IgG response against 
the 29kDa protein as compared to asymptomatic controls, raising the possibility of the use of this 
protein as a pathogenicity marker for Blastocystis isolates. Given the increasing evidence of 
genotype/ST dependent pathogenicity, it is essential to characterise the genotype/ST of the 
Blastocystis isolate used, a step which is lacking in these studies. 
 
1.11 Animal Infectivity Models 
Up till now there is still a lack of a recognised animal infection model for Blastocystis infection. As 
a result Koch’s postulates cannot be fulfilled and the pathogenicity of Blastocystis cannot be 
determined as yet. To date, experimental infections have been conducted in guinea pigs, mice, 
chickens and rats with conflicting and inconclusive results. Mild pathology and self-limiting disease 
has been observed in mice while moderate to severe pathology has been observed in some chickens 
and rats with various strains of Blastocystis (Iguchi et al., 2007; Moe et al., 1997; Phillips and 
Zierdt, 1976; Yoshikawa et al., 2004c). 
 
Mice have been shown not to be naturally infected with Blastocystis whereas rats and chickens 
seem to be naturally infected with ST4 and STs 6/7, respectively, however they do not seem to 
harbour other STs, therefore these hosts are unlikely to make suitable animal models (Iguchi et al., 
2007; Moe et al., 1997; Phillips and Zierdt, 1976; Tan, 2008; Yoshikawa et al., 2004c). Reported 
histopathological findings in these animal infection studies include inflammation, mucosal 
sloughing, mild lamina propria oedema and Blastocystis organisms mainly in luminal material or at 
the epithelial edge in the caecum and colon of infected mice (Moe et al., 1997), while on the other 
hand Phillips and Zierdt (1976) reported minimal increase in cellularity of lamina propria with the 
frequent presence of numerous Blastocystis organisms invading the epithelium of guinea pigs. 
Interestingly enough, the above histological findings have not been reported in humans with 
Blastocystis infection (Clark et al., 2013). 
 
Additionally, there have been various human studies as well as in vitro cell studies on Blastocystis. 
In a study by Dagci et al. (2002), Blastocystis infected humans were shown to have increased 
intestinal permeability (measured using 99mTc labelled DTPA assay) as compared to the control 
group. A similar finding was observed in an in vitro study using the non-transformed rat intestinal 
epithelial cell line, IEC-6, inoculated with live Blastocystis organisms or lysate (Blastocystis isolate 
WR1) (Puthia et al., 2006). 
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The lack of a recognised animal model led us to investigate which species other than humans and 
the above mentioned animals might be a suitable host. The main objective of our studies were to 
ascertain if dogs and/or pigs would make suitable candidates for animal model development for 
blastocystosis by firstly investigating if they are indeed natural hosts of Blastocystis, as suggested 
by previous reports. Our selection criteria for a natural host was the following: (i) a host which 
commonly harbour Blastocystis (i.e. high prevalence) and (ii) harbours  a predominant host-adapted 
ST/s. Ideally, the host should be able to harbour common STs that humans are infected with as well, 
namely STs, 1, 2, 3 and 4, otherwise STs 5-9 which are less common. 
 
Dogs in Brisbane had been shown to have a high prevalence of Blastocystis (Duda et al., 1998); 
they are able to harbor similar Blastocystis STs to humans and could be a potential source of 
Blastocystis infection in humans (Nagel et al., 2012). In a recent study by Nagel et al. (2012), 59% 
of household contacts and all domestic animals (i.e. dogs, cats) of 11 symptomatic Blastocystis 
patients were found to harbour at least one Blastocystis ST in common with the patient. Based on 
this evidence, dogs could be the next most suitable host for animal model development for 
blastocystosis. As part of our first experiment, we investigated the molecular epidemiology of dogs 
in three different geographical regions to ascertain if there were indeed natural hosts of Blastocystis 
and to characterise the STs they harboured. 
 
Blastocystis has been reported in pigs in some countries, with most pigs harbouring ST5 or ST1 and 
occasionally ST2 or ST3 (Alfellani et al., 2013c; Navarro et al., 2008; Thathaisong et al., 2003). A 
molecular study by Navarro et al. (2008) in intensively reared pigs in Valencia, Spain, found ST1 to 
be most prevalent in infected pigs (44.6%) and, to a lesser extent, ST2. Subtype 5 has been found 
not only in pigs but also in cattle, other livestock and captive apes (Alfellani et al., 2013a; Stensvold 
et al., 2009a) but rarely in humans. The potential of pigs to act as zoonotic reservoirs of Blastocystis 
has been demonstrated by Yan et al. (2007) where the investigators found two human ST5 isolates 
had restriction fragment length polymorphism (RFLP) patterns identical or similar to those in 16 
pigs living in the same rural area in China. The preceding studies had been conducted either in 
different geographical regions (such as Spain, Japan, China), with a relatively small sample size or 
the diagnosis was obtained with non-molecular methods so subtyping was not possible (Abe et al., 
2002; Navarro et al., 2008; Yan et al., 2007). For these reasons, we also decided to investigate pigs 
as a potential candidate for model development.  
  
19 
 
1.12 Hypotheses and aims  
 
Hypothesis 1 (Dog prevalence study):  
 a) If Dogs are natural hosts of Blastocystis, then screening populations using faecal PCR will 
result in one or more ST/s being commonly amplified, presumably the host adapted ST/STs. 
 b) If Dogs harbour (as determined by PCR on faecal samples) similar Blastocystis ST/s to 
humans, they may be zoonotic reservoirs of Blastocystis. 
Aim 1:  Investigate the molecular epidemiology of Blastocystis in pet/pound/stray dogs in three 
different geographic and environmental settings. 
 
Hypothesis 2 (Pigs and piggery staff prevalence study): 
 a) If pigs are natural hosts of Blastocystis, then screening populations using faecal PCR 
will result in one or more ST/s being commonly amplified. 
 b) If Pigs harbour similar Blastocystis ST/s to their in-contact humans, then they may be 
zoonotic reservoirs of Blastocystis. 
Aim 2:  Investigate the molecular epidemiology of Blastocystis in pigs and their potential role as 
sources of zoonotic Blastocystis for in-contact humans in two different geographic and 
environmental settings. 
 
Hypothesis 3 (Intestinal study):  If pigs are good candidates for an animal model, then Blastocystis 
organisms will behave as reported in humans. Specifically, they will reside predominantly in the 
large intestine and cause minimal/no pathology in these hosts. ; whereas clinical disease in 
minority of the infected hosts may be associated with other disease causing mechanisms. 
Aim 3: Define the location of Blastocystis ST/s in the pig intestine and identify any organic 
pathology associated with infection.  
 
Hypothesis 4 (serological study): If functional immunomodulation rather than organic pathology 
results in Blastocystis associated disease,  then this may be evident in differences in Blastocystis 
specific host IgA immune response according to various factors (e.g. age group, immune status, 
infecting ST). 
 Aim 4: Characterisation of the Blastocystis specific faecal IgA response in pigs, using Western 
blotting, to determine whether reactivity against any particular antigen correlates with age group, 
immune status or infecting ST. 
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Chapter 2:                                   
Diversity of Blastocystis subtypes in 
dogs in different geographical settings 
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2.1 Manuscript Information 
 
Wang W., Owen H., Traub R.J., Cuttell L., Inpankaew T., Bielefeldt-Ohmann H., 2013. Diversity 
of Blastocystis subtypes in dogs in different geographical settings. Parasit Vectors 6, 215-219. 
 
Previous studies on Brisbane dogs had demonstrated that Blastocystis infection is prevalent in 
pound dogs (Duda et al., 1998) and that pet dogs harboured similar STs to that of their in-contact 
human owners (Nagel et al., 2012), thus suggesting that they may be natural hosts and/or potential 
zoonotic reservoirs of Blastocystis. This led us to investigate the suitability of dogs as animal 
models for human blastocystosis. In this study, we aimed to study the molecular epidemiology of 
Blastocystis in dogs in three different geographic settings, namely pet/pound dogs in Brisbane, 
community dogs in rural Cambodia and stray dogs in India using PCR. 
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Abstract
Background: Blastocystis is a ubiquitous, globally distributed intestinal protist infecting humans and a wide range
of animals. Several studies have shown that Blastocystis is a potentially zoonotic parasite. A 1996 study reported a
70% Blastocystis prevalence in Brisbane pound dogs while another study found that pet dogs/cats of 11
symptomatic Blastocystis infected patients harboured at least one Blastocystis subtype (ST) in common with the
patient. These results raised the possibility that dogs might be natural hosts of Blastocystis. In this study, we aimed
to investigate this hypothesis by estimating the prevalence of Blastocystis carriage and characterising the diversity
of STs in dogs from three different environmental settings and comparing these STs with the range that humans
harbour.
Methods: Two hundred and forty faecal samples from dogs from three different geographical regions with varying
levels of socio-economic development and sanitation, namely i) 80 pet and pound dogs from Brisbane, Australia,
ii) 80 semi-domesticated dogs from Dong Village, Cambodia and iii) 80 stray dogs from the densely populated
cities of Sikkim, Delhi and Mumbai in India, were screened for Blastocystis using PCR and subtyped based on the
“barcode region” of the small subunit ribosomal RNA (SSU rRNA) gene.
Results: The prevalence of Blastocystis in dogs from Brisbane and Cambodia was 2.5% (2/80) and 1.3% (1/80),
respectively, in contrast to 24% (19/80) in stray dogs from India. Stray dogs in India carried a diverse range of
Blastocystis STs including ST 1, 4, 5 and 6 while the dogs from Brisbane carried only ST1 and one Cambodian dog
carried ST2.
Conclusion: The results suggest there is geographical variation in Blastocystis prevalence and STs between dog
populations as reported in human studies. In addition, the greater diversity of STs and higher prevalence of
Blastocystis in Indian stray dogs compared to pet/pound and community dogs in Australia and Cambodia could
reflect close proximity to humans and other animals and exposure to their faeces. It appears that dogs are not
natural hosts for Blastocystis but rather are transiently and opportunistically infected with a diversity of STs.
Keywords: Blastocystis, Dog, Zoonosis, Epidemiology
Background
Blastocystis is a ubiquitous, intestinal protist with a high
prevalence worldwide in humans and animals. Host types
shown to carry Blastocystis include humans, non-human
primates, a range of domesticated and wild mammals and
birds [1]. Blastocystis is the most common gastrointestinal
parasite recovered in human fecal parasite surveys, with
prevalence ranging from 0.5% in developed countries to
60% in developing countries [2]. The most accepted
proposed mode of transmission is the fecal-oral route ei-
ther by direct contact or food and water-borne transmis-
sion [3-5]. Molecular analysis of the SSU-rRNA gene has
allowed for subdivision of Blastocystis into 14 distinct sub-
types (STs) in humans, non-human primates (NHPs),
mammals and birds [1,6,7]. Humans have been shown to
carry STs 1–9, with ST3 being the most prevalent followed
by ST1 [8].
Blastocystis is a potential zoonosis as suggested by a
number of studies that have isolated identical STs of
Blastocystis from humans and their in-contact animals
[3-6,9]. Recently, domestic dogs were proposed as a
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potential source of Blastocystis infection to humans
[10]. Eleven symptomatic patients, their pets, as well
as 59% of family members tested positive for
Blastocystis by PCR and all infected family members
and domestic animals (dogs and cats) harboured at
least one Blastocystis ST in common with the patient.
A study by Duda et al. [11] on Blastocystis prevalence
in 72 domestic dogs (70 pound dogs and 2 pet dogs) in
Brisbane showed a 70.8% prevalence using light micros-
copy on fecal wet mounts. These results raised the possi-
bility that dogs might be natural hosts of Blastocystis and
potential sources of zoonotic transmission to humans.
In this study, we aimed to investigate this hypothesis by
estimating the prevalence of Blastocystis infection and
characterising the diversity of STs in dogs from three
different environmental settings and comparing these
STs with the known range harboured by humans.
Methods
Sampling
A total of 240 dogs were screened for Blastocystis, in-
cluding 80 dogs from each of the 3 following settings 1)
pound and pet dogs in Brisbane, a major metropolitan
area in Queensland, Australia 2) semi-domesticated
dogs from 36 households in Dong Village, Cambodia,
3) stray street dwelling dogs from the Indian cities of
Delhi, Sikkim and Mumbai. The three settings differed
from each other in terms of geographical location, level
of hygiene and opportunities for dogs to come into
contact with faeces from humans and other animals.
In Brisbane, freshly voided faecal samples were col-
lected off the ground from pet and pound dogs. These
samples were obtained in 2010 – 2011 from 45 pound
dogs and 35 pet dogs. Samples were stored at room
temperature until DNA extraction was performed, usu-
ally within 12 hours. In Cambodia, faecal samples were
collected per-rectum from 80 semi-domesticated dogs
from 36 households in the Dong village and preserved in
2.5% potassium dichromate (K2Cr2O7) (Sigma-Aldrich,
Australia) until DNA extraction was performed. In India,
stray dogs were sampled from three cities, namely Sikkim
(n = 25), Delhi (n = 27) and Mumbai (n = 28) in 2008 as
part of a street dog sterilization project run by Non-
Governmental Organisations and municipalities. Faecal
samples were collected from stray dogs per-rectum and
preserved in 70% ethanol. This project was approved by
the University of Queensland Animal Ethics Committee
with approval no. ANRFA/472/11.
Molecular analysis
DNA extraction
DNA was extracted from faeces using the QIAamp
DNA Stool Mini Kit (Qiagen, Germany) with minor
modifications. Following addition of buffer ASL and
homogenisation, samples were subjected to freeze/thaw
3 times repeatedly in liquid nitrogen and 95°C water,
followed by a further 5 mins incubation at 95°C to lyse
cells.
Control testing of extracted DNA
For internal process control, all samples were tested
using published universal primers that amplify a 140 bp
fragment of the 18S ribosomal RNA gene from eukaryotic
DNA to detect for amplifiable DNA [12]. The primers
used were forward: 18SEUDIR 5′-TCTGCCCTATCAA
CTTTCGATGG-3′ and reverse: 18SEUINV 5′-TAATT
TGCGCGCCTGCTG-3′. PCR cycling conditions were
optimised by modifying the published real-time PCR
protocol using an annealing temperature of 60°C. This
testing was performed to check for inhibition and also en-
sure that the variation in the sample preservation methods
would not affect the accuracy of results.
PCR amplification
Two previously published PCR primer sets and condi-
tions were utilised for the detection and characterisation
of Blastocystis STs [13-15]. A single step [14] and nested
PCR [13,15] were performed on each sample using a
Bio-Rad C1000 Thermal Cycler (Bio-Rad Laboratories,
Inc., Hercules, USA) (Table 1) to amplify a 600 bp and
1100 bp region of the SSU rRNA gene, respectively. De-
tails of primer sets and PCR cycling conditions are
outlined in Table 1.
Phylogenetic analysis
PCR products were purified using the PureLink Genomic
DNA Mini Kit (Life Technologies Corporation, New York,
USA) according to the manufacturer’s protocol. Unidirec-
tional DNA sequencing was carried out using the respec-
tive reverse primers with an Applied Biosystems 3130/
3130xl Genetic Analyzer. DNA sequences were analysed
using Finch TV v 1.4.0 (Geospiza Inc., Seattle, WA, USA)
and compared with previously published sequences from
GenBank (National Center for Biotechnology Informa-
tion) using Basic Local Alignment Search Tool (BLAST)
2.2.9 [16]. The sequences were aligned with previously
published sequences of the SSU rRNA gene of the various
Blastocystis STs sourced from GenBank using BioEdit v
7.1.3.0 software (Ibis Biosciences, Carlsbad, CA, USA).
Neighbour joining analysis and construction of a tree
was carried out using Mega 4.1 software (The Biodesign
Institute, Tempe, AZ, USA). Proteromonas lacerate
(U37108) was used as an out-group.
Statistical analysis
Prevalence and their 95% confidence intervals for each
group of dogs were calculated using EpiTools epidemio-
logical calculators [17].
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Results and discussion
Summary of PCR results are shown in Tables 2 and 3.
Of the 80 Indian dogs tested, 19 (24%; 95% CI, 14.4,
33.1) were positive for Blastocystis with a predominance
of ST1 and ST6. The Blastocystis prevalence in the cit-
ies of Sikkim, Mumbai and Delhi were 24% (6/25), 14%
(4/28) and 33% (9/27) respectively, with dogs in all cit-
ies harbouring ST 1, 4, 5 or 6. Of the 80 Brisbane dogs,
2 (2.5%, 95% CI, 0, 5.9) samples were positive, both
were from pound dogs and were ST1. Of the 80
Cambodian dogs, 1 (1.3%, 95% CI, 0, 3.7) was positive
for ST2. The Brisbane prevalence results of our study
are in contrast to those of Duda et al. [11] who found,
using light microscopy only, that 70.8% of pound dogs
from Brisbane harbored Blastocystis, a much higher
prevalence than the 2.5% described here. This discre-
pancy could be attributed to the level of care and hy-
giene of the pound dogs in 1998 compared to current
standards, while the source of acquisition and duration
of stay within the pound or other confounding factors
could have influenced Blastocystis prevalence. On the
other hand, Blastocystis is a morphologically pleo-
morphic organism and the extensive variation in the
appearance of the recognized forms of Blastocystis may
lead to operator misinterpretations [2,18,19] and in this
case, potentially, a high rate of false positives.
Blastocystis prevalence can vary between countries and
subpopulations, however, the general trend in previous
prevalence studies is that developing countries have a
higher prevalence than that of developed countries [2].
Prevalence can range from as low as 3.3% in human
samples from hospitals in Singapore [20] to 49% in sam-
ples from a Nigerian clinic and 70% in children in three
counties in Liberia as reported in a ST distribution study
by Alfellani et al. [8]. Both studies used PCR for diagno-
sis. In humans, these differences can be attributed to
poorer sanitation, higher risk of food and water contam-
ination and also greater exposure to animals and their
excrements in developing countries as compared to the
developed countries [2,4,21]. Our study, however, did
not clearly discriminate between the prevalence of
Blastocystis between dogs living in developing and devel-
oped communities. Mumbai, Delhi and Sikkim have
been described as densely populated cities in India with
inadequate toileting facilities and sewage systems leaving
large sectors of these cities with poor sanitation and hy-
giene especially in the slum areas [22,23]. As a result, it is
estimated that greater than 50% of resource-poor commu-
nities within urban areas practice open defecation [23,24].
This may explain the discrepancy between the prevalence
of Blastocystis in the Indian stray dogs as compared to the
Brisbane dogs, however, it does not account for the negli-
gible prevalence of Blastocystis in semi-domesticated com-
munity dogs in rural Cambodia.
The Indian stray dogs in this study harbored ST 1, 4, 5
and 6 while the Brisbane and Cambodian dogs harbored
only ST1 and ST2, respectively. Recently, Alfellani et al.
[8,25] consolidated the results of multiple studies on
Blastocystis ST distribution in humans and NHPs in
Table 1 PCR primer sets for amplification of SSU rRNA region of Blastocystis from dog faeces
Primer Primer name and sequence (5′ to 3′) Product size
Single step PCR conditions as per Scicluna et al. [14] BhRDr -GAGCTTTTTAACTGCAACAACG 600 bp
RD5 –ATCTGGTTGATCCTGCCAGT
Nested PCR–primary set, conditions as per Clark [13] RD3-GGGATCCTGATCCTTCCGCAGGTTCACCTAC 1800 bp
RD5 -GGAAGCTTATCTGGTTGATCCTGCCAGTA
Nested PCR – secondary set, conditions as per Bohm-Gloning [15],
using 1 ul of PCR product from primary step.
Forward -GGAGGTAGTGACAATAAATC 1100 bp
Reverse - CGTTCATGATGAACAATTAC
Table 2 PCR results of dog faecal samples
Positive Blastocystis
STs
Negative
Indian street dogs (80)
(preserved in ethanol)
19 (24%) ST1 – 9 61 (76%)
ST6 – 7
ST4 – 2
ST5 – 1
Brisbane dogs (80)
(fresh samples)
2 (2.5%,
pound dogs)
ST1 - 2 78 (97.5%)
Cambodian dogs (80)
(preserved in 2.5% K2Cr2O7)
1 (1.3%) ST2 – 1 79 (98.7%)
Table 3 PCR results of dog faecal samples based on
individual primer sets
PCR Indian street
dogs
Brisbane
dogs
Cambodian dogs
Single step
PCR
ST1 – 8 ST1 - 2 ST2 – 1
ST4 – 2
ST 5 – 1
ST6 – 2
Nested PCR ST1 – 1 All negative ST2 – 1
ST6 – 5 (same sample as above)
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several countries. The most common human STs in the
UK for example, were ST3 and 4, while in Africa it was
ST1 and 3 [8]. In the NHP study, they found that distri-
bution of ST1, 2 and 3 appeared to be independent of
geographical association or NHP group, whereas ST 8
was only observed in arboreal NHPs and species native
to Asia or South America [25]. Collectively the results
show variable geographical distribution of Blastocystis
STs in both humans and NHPs between and within sub-
populations of different countries. This hypothesis of
geographical variation of STs might, at least in part, ex-
plain the results in this study, where we found different
STs in dogs in different geographical regions except for
ST1 which was found in both Indian and Brisbane dogs.
The general low prevalence of Blastocystis and the
diversity of STs found in dogs in three different geo-
graphical regions/ settings suggest that dogs may be
transiently and opportunistically infected by whichever
Blastocystis ST is present in their environment, be it
from a human or non-human source. Therefore, dogs
are unlikely to act as either natural hosts or primary
zoonotic reservoirs for Blastocystis but are capable of
shedding potentially zoonotic STs and may therefore act
as secondary zoonotic reservoirs for infection. The
Blastocystis STs observed in dogs in this study include
STs 1, 2, 4, 5 and 6. ST1 is one of the most common hu-
man STs, ST2 is common in UK, Brazil and Central
Asia, while ST4 is very common in humans in the UK
but rare in other countries [8], though rodents have
been shown to be the main animal reservoir of ST4 [1].
ST5 is rare in humans but otherwise commonly reported
in ungulates (e.g. pigs, cattle), whereas ST6 is uncom-
mon in humans but otherwise reported mainly in avian
species [1,9,26]. Keeping this in mind and the fact that
coprophagia is common practice in dogs, the greater
prevalence and diversity of STs found in the Indian stray
dogs could be attributed to higher population density
and greater exposure in their environment to fecal ma-
terial from human and non-human hosts (cattle, pigs,
avians, NHPs), from which they could have either mech-
anically passaged or acquired opportunistic infections
with various Blastocystis STs. Ideally, studies to ascertain
the relative prevalence of Blastocystis STs in humans
and animals residing in these three geographical regions
especially that of the urban centres in India would pro-
vide a clearer epidemiological picture of transmission
pathways. Additionally, given that extensive genetic di-
versity exists within Blastocystis STs, ideally future mo-
lecular characterisation and comparison of dog, human
and other mammalian Blastocystis STs using multilocus
sequence typing (MLST) performed within communi-
ties endemic for Blastocystis in dogs and humans will
shed further light on their role as natural hosts for in-
fection [27].
Conclusions
Our results show that a diverse range of Blastocystis STs
(ST1, 2, 4 ,5 and 6) can be found in dogs and it is likely
that there is geographical variation of STs in dogs as has
been shown in humans and NHPs [8,25]. Secondly, con-
sidering the low prevalence of Blastocystis in dogs with
no indication of dog-specific/predominant ST, they are
unlikely to be natural hosts of Blastocystis and are po-
tentially opportunistically infected via coprophagia of
other hosts faeces or contaminated drinking water.
Larger scale Blastocystis epidemiological studies on
humans and dogs from the same geographical areas with
SSU rDNA (18S) allele analysis or MLST would be re-
quired to confirm this hypothesis.
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In the previous study we demonstrate that dogs generally had a low prevalence of Blastocystis and 
did not appear to have a predominant host ST/s (Wang et al., 2013). Given this, we concluded that 
they were unlikely to be natural hosts of Blastocystis and were probably transiently and 
opportunistically infected with various STs through regular exposure to faeces from other species, 
therefore they were not suitable for animal model development (Wang et al., 2013). On the other 
hand, Blastocystis carriage has been commonly reported in pigs in many countries (Alfellani et al., 
2013c; Navarro et al., 2008; Yan et al., 2007) and it has also been proposed that ST5 from pigs may 
have zoonotic potential (Yan et al., 2007). In this study, we aimed to investigate the molecular 
epidemiology of Blastocystis in pigs and also their in-contact human handlers in two difference 
geographical and environmental settings, namely intensive piggeries in SEQ and a rural village in 
Cambodia. 
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a  b  s  t  r  a  c  t
Blastocystis,  an  intestinal  protist  commonly  found  in  humans  and  animals  worldwide,  has
been implicated  by some  as  a causative  agent  in  irritable  bowel  syndrome  in  humans.  In
pigs, infection  with  Blastocystis  is commonly  reported,  with  most  pigs  shown  to harbour
subtypes  (ST)  1 or 5, suggesting  that these  animals  are  potentially  natural  hosts  for  Blas-
tocystis.  Although  ST5  is  considered  rare  in  humans,  it has  been  reported  to  be  a potential
zoonosis  from  pigs  in rural  China.  To  test  these  hypotheses,  we conducted  molecular  analy-
sis  of  faecal  samples  from  pigs  and  in-contact  humans  from  commercial  intensive  piggeries
in Southeast  Queensland  (SEQ),  Australia,  and a village  in  rural  Cambodia.  The  prevalence
of  Blastocystis  in SEQ  and  Cambodian  pigs  was  76.7%  and  45.2%,  respectively,  with  all  posi-
tive pigs  harbouring  ST5.  It  appears  likely  that  pigs  are  natural  hosts  of Blastocystis  with  a
high  prevalence  of ST5  that  is presumably  the pig-adapted  ST in these  regions.  Amongst  the
SEQ piggery  staff,  83.3%  were  Blastocystis  carriers  in  contrast  to only  55.2%  of  Cambodian
villagers.  The  predominant  STs  found  in  humans  were  STs 1,  2 (Cambodia  only)  and  3. Inter-
estingly,  ST5 which  is  usually  rare  in humans  was  present  in the  SEQ  piggery  staff  but  not
in the  Cambodian  villagers.  We  conclude  that  in  intensive  piggeries,  close  contact  between
pigs and  their  handlers  may  increase  the  risks  of zoonotic  transmission  of  Blastocystis.
© 2014  Elsevier  B.V.  All  rights  reserved.
1. Introduction
Blastocystis is an intestinal protist that is commonly
found worldwide in a diverse range of species including
humans, non-human primates (NHPs), other mammals and
birds (Alfellani et al., 2013c; Stensvold et al., 2009). Blas-
tocystis is genetically polymorphic and molecular analysis
∗ Corresponding author. Tel.: +61 7 5460 1834; fax: +61 7 5460 1922.
E-mail address: w.wang3@uq.edu.au (W.  Wang).
of the small subunit ribosomal RNA (SSU rRNA) gene has
enabled division of this organism into 17 distinct subtypes
(STs) found in a wide range of species (Alfellani et al.,
2013c; Fayer et al., 2012; Parkar et al., 2010; Stensvold
et al., 2009). Some STs show significant intra-ST genetic
variability (Scicluna et al., 2006; Stensvold et al., 2012;
Yoshikawa et al., 2009). Humans have been shown to carry
STs 1–9 with ST3 the most frequently reported. Signifi-
cant geographical variation in the prevalence and relative
proportion of STs is known to exist, with other common
STs including 1, 2 and 4 (Alfellani et al., 2013b). Faecal
http://dx.doi.org/10.1016/j.vetpar.2014.04.006
0304-4017/© 2014 Elsevier B.V. All rights reserved.
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oral transmission either by direct contact or water-borne
transmission is currently the most accepted mode of trans-
mission (Lee et al., 2012b; Leelayoova et al., 2004, 2008).
Previous studies have isolated identical STs of Blastocystis
from humans and their in-contact animals including pigs
(Lee et al., 2012a,b; Nagel et al., 2012; Parkar et al., 2007,
2010; Stensvold et al., 2009; Yan et al., 2007), suggesting
potential zoonotic transmission of Blastocystis.
Blastocystis has been reported in pigs in some countries,
with most pigs harbouring ST5 or ST1 and occasionally
ST2 or ST3 (Alfellani et al., 2013c; Navarro et al., 2008;
Thathaisong et al., 2003; Yan et al., 2007). In Valencia, Spain,
Navarro et al. (2008) found ST1 to be the most prevalent
among intensively reared pigs and, to a lesser extent, ST2.
ST5 has also been identified in cattle, other livestock and
captive apes (Alfellani et al., 2013b; Stensvold et al., 2009),
but rarely in humans. The potential of pigs to act as zoonotic
reservoirs of Blastocystis was demonstrated by Yan et al.
(2007) in which two human ST5 isolates had restriction
fragment length polymorphism (RFLP) patterns of the SSU
rDNA were either identical or similar to those of 16 pigs
living in the same rural area in China.
The objective of this study was to ascertain if pigs are
suitable animal models for studying Blastocystis infection
by investigating if they are indeed natural hosts of Blas-
tocystis as suggested by previous reports. Our selection
criteria for a ‘natural host’ was based on (i) a host which
commonly harbour Blastocystis (i.e. at a high prevalence)
and (ii) of a predominant ST or STs. The second objective
was to investigate the zoonotic potential of porcine Blas-
tocystis by testing and genetically comparing Blastocystis
recovered from pigs and their in-contact humans (i.e. pig-
gery staff and villagers).
Preceding studies investigating Blastocystis infection in
pigs have been limited by their relatively small sample size
and lack of molecular identification of Blastocystis ST (Abe
et al., 2003; Navarro et al., 2008; Yan et al., 2007). In this
study we genetically characterise the STs of Blastocystis
in pigs and their in-contact humans in two different sett-
ings (intensive versus small holder piggeries) in Southeast
Queensland (SEQ), Australia, and a rural Cambodian village.
2. Materials and methods
2.1. Sampling
2.1.1. Southeast Queensland (SEQ)
Single faecal samples were collected from 240 pigs
and 36 piggery staff from 18 commercial piggeries in SEQ
between February 2012 and February 2013 and stored in
2.5% potassium dichromate prior to DNA extraction. The
faecal samples were collected from approximately 10–25
pigs at various stages of production (piglets, weaners,
growers and sows) per piggery.
2.1.2. Cambodia
Single faecal samples were collected in May  2012 from
73 pigs and 210 villagers from 41 households in Dong vil-
lage, Preah Vihear province, Cambodia and stored in 2.5%
potassium dichromate prior to DNA extraction. The major-
ity of the households sampled (29/41) owned pigs and up to
0–4 pig and 1–9 human samples were collected per house-
hold.
2.1.3. Ethical approval
The SEQ segment of this project was approved by the
University of Queensland Animal Ethics Committee and
Medical Research Ethics Committee with approval no.
ANRFA/472/11 and 2012000069, respectively. Sample col-
lection from the Cambodian village was  made possible
by collaboration between the University of Copenhagen,
Denmark, Department of Fisheries Post-Harvest Technolo-
gies and Quality Control, Cambodia, and the National
Center for Parasitology, Entomology and Malaria con-
trol, Cambodia. The study protocol was  approved by the
National Ethics Committee Health Research, Ministry of
Health in Cambodia. All persons were informed on the pur-
pose of the study. Written informed consent was obtained
from all individuals prior to enrolment.
2.2. Molecular analysis
2.2.1. DNA extraction
Faeces stored in 2.5% potassium dichromate was
washed twice in 1× phosphate-buffered saline and cen-
trifuged before the sediment was used for DNA extraction.
DNA was  extracted using the QIAamp DNA Stool Mini Kit
(Qiagen, Germany) with minor alterations as per Wang
et al. (2013).
2.2.2. PCR amplification with nested PCR
Samples were first tested with a previously published
nested PCR primer set and conditions that amplified an
1100 bp region of the Blastocystis SSU rRNA gene (Clark,
1997; Wong et al., 2008) (Table 1). This method was  chosen
since it provides a large fragment for phylogenetic analysis,
and as it is a pan-Blastocystis technique, it allows for iden-
tification of known and unknown STs of Blastocystis. Each
25 l PCR reaction was run using approximately 50 ng of
DNA and the conditions were as per Clark (1997) and Wong
et al. (2008).
2.2.3. Phylogenetic analysis
All positive PCR products were purified using the
PureLink Genomic DNA Mini Kit (Life Technologies Cor-
poration, New York, USA) according to the manufacturer’s
protocol. Unidirectional DNA sequencing was  performed
with the reverse primer of the secondary PCR with an
Applied Biosystems 3130/3130xl Genetic Analyzer. The
DNA sequences were first analysed with Finch TV v 1.4.0
(Geospiza Inc., Seattle, WA,  USA) and subsequently com-
pared with published sequences from GenBank (National
Center for Biotechnology Information) using BLAST 2.2.9
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). These sequences
were then aligned with previously published sequences of
the SSU rRNA gene of the various Blastocystis STs, which
were sourced from GenBank using BioEdit v 7.1.3.0 soft-
ware (Ibis Biosciences, Carlsbad, CA, USA). The sequences
were subsequently analysed using Mega 4.1 software (The
Biodesign Institute, Tempe, AZ, USA) to construct a neigh-
bour joining tree for subtyping of the Blastocystis isolates.
Proteromonas lacertae (U37108) was used as an out-group.
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Table 1
PCR primers for amplification of partial fragments of the Blastocystis small
subunit ribosomal RNA (SSU rRNA) used to genetically characterise SEQ
and Cambodian Blastocystis isolates.
Primer/annealing
temperature (◦C)
Primer name and
sequence (5′–3′)
Product size
Nested PCR – primary
set, (65 ◦C; Clark,
1997)
RD3
GGGATCCTGATCCTTC-
CGCAGGTTCACCTAC
RD5 GGAAGCTTATCTG-
GTTGATCCTGCCAGTA
1800 bp
Nested PCR –
secondary set, (49 ◦C;
Wong et al., 2008;
using 1 l of PCR
product from
primary step.)
Forward GGAGGTAGT-
GACAATAAATC
Reverse ACTAG-
GAATTCCTCGTTCATG
1100 bp
STS  1
(57 ◦C)
Forward TAATACATGA-
GAAAGTCCTCTGG
Reverse CTCAATC-
CAATTGCAAGAC
336 bp
STS 2
(65 ◦C)
Forward
GCTCGTAGTTGAAGT-
GAGGGAGTG
Reverse ATCGAACAC-
GAAAGCCTTCAATC
203–204 bp
STS 3
(58 ◦C)
Forward GATTGAGAA-
CAACGTACAAACC
Reverse ATGAAC-
CAAACCAATCAAATAC
339–341 bp
STS 5
(56 ◦C)
Forward GTAAATGAC-
CAATTCTTATTAC
Reverse GTGGGAT-
GAAGTATATGATG
106 bp
The ST1, ST3 and ST5 sequences from pigs and humans
were compared using multiple sequence alignment by
Mega 4.1 software (The Biodesign Institute, Tempe, AZ,
USA).
2.2.4. Development of subtype-specific (ST-specific)
primers
Pan-subtype targeted PCRs can result in preferential
amplification of predominant STs over others in mixed
infections. Therefore, we developed and applied ST-specific
primers for STs 1, 2, 3 and 5 (Table 1) based on the STs iden-
tified in the humans and pigs using nested PCR. Application
of ST-specific PCRs aimed to investigate whether greater
than single ST infections were present in each host and
to increase the probability of determining whether cross-
transmission of Blastocystis was occurring between pigs
and humans in the same geographical setting. ST-specific
primers for STs 1, 3 and 5 were designed based on the “bar-
code” region of the Blastocystis SSU rRNA gene, while the
ST-specific primers of ST2 were designed from the non-
barcode region of the SSU rRNA (see acknowledgement).
The respective primers were tested against STs 1–6 DNA,
respectively to ensure the absence of cross-reactivity. The
following protocol was followed (1) All human samples
were tested with ST5-specific primers, regardless of Blas-
tocystis status, (2) porcine samples with suspected mixed
infections (characterised by overlapping double peaks at
single nucleotide polymorphisms) were tested with ST-
specific 1, 3 and 5 primers (Table 2). In addition, Cambodian
pigs were also tested with ST-specific 2 primers as this ST
was  also found in Cambodian villagers, but not in SEQ staff.
Lastly, porcine samples diagnosed with STs 1 or 3 (Table 2)
were tested with ST-specific 5 primers to ensure mixed
infectious with ST5 were not overlooked, as this was the
predominant ST found in both pig populations. When an
“aberrant” ST was found in pigs or humans with ST-specific
primers (i.e. ST5 in humans and STs 1 or 3 in pigs), the PCR
products were sequenced and compared with sequences of
the same ST from the other host (humans/pigs).
PCR reaction mixtures for ST-specific primers were sim-
ilar consisting of 50 ng of faecal genomic DNA, 1.0 units of
HotStar Taq Plus DNA Polymerase (Qiagen, Germany) and
10 pmol of each forward and reverse primer. The MgCl2
concentration was optimised for each primer pair and
ranged from 0.5 to 1.5 mmol/l. Nuclease free water was
added to adjust the final reaction volume to 25 l. Positive
controls for each ST and a negative control (2 l of distilled
water) were included in each PCR run. Primer sequences
and cycling conditions are presented in Table 1.
2.2.5. Control testing of samples
As part of internal process control, we tested all samples
that were negative using the Blastocystis-specific nested
PCR for the presence of amplifiable DNA and to rule out
potential PCR inhibition. These samples were tested using
published universal primers that amplify a 140 bp frag-
ment of the 18S ribosomal RNA gene from eukaryotic DNA
(Fajardo et al., 2006). PCR cycling conditions were modified
from a real-time PCR protocol to a conventional protocol
using an annealing temperature of 60 ◦C as recommended.
2.2.6. Statistical analysis
The percentage prevalence of each test group and
95% confidence intervals were calculated using Epi-
tools epidemiological calculators (AusVet Animal
Health Services and Australian Biosecurity Coopera-
tive Research Centre for Emerging Infectious Disease,
http://epitools.ausvet.com.au). Chi-squared (2) tests
were used to compare the Blastocystis prevalence between
the Cambodian and SEQ pigs and humans respectively.
A p-value of less than 0.05 was considered statistically
significant. The statistical software used was Calculation
for the Chi-Square test: An interactive calculation tool
for chi-square tests of goodness of fit and independence
(Preacher, 2001).
3. Results and discussion
The prevalence of Blastocystis in both populations of pigs
was  high (SEQ 76.7%; Cambodia 45.2%) (Table 2), but was
significantly higher in the SEQ pigs than in the Cambodian
pigs (p < 0.05; Table 3). All SEQ piggeries (18/18) and major-
ity (24/29) of the pig-rearing households in the Cambodian
village contained pigs that were positive for Blastocystis. All
infected SEQ and Cambodian pigs harboured ST5 (Table 4).
This included 17 (7.1%) SEQ pigs with mixed infections of
ST5 and ST1 and/or ST3, or ST5 and unknown mixed STs
While no mixed infections (with STs 1, 2, 3 and 5) were
detected in the Cambodian pigs (Table 4).
The high Blastocystis prevalence, in addition to the pre-
dominance of ST5 in both pig populations, corroborated the
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Table  2
Prevalence of Blastocystis infection in SEQ and Cambodian pig and human samples using the nested PCR primer set and subtype characterisation by sequence
analysis.
Infection SEQ pigs (n = 240) Cambodian pigs (n = 73) SEQ piggery staff (n = 36) Cambodian villagers (n = 210)
% positive 76.7% (184) 45.2% (33) 83.3% (30) 55.2% (116)
ST  1 4 0 11 33
ST  2 0 0 0 27
ST  3 4 0 16 45
ST  5 167 20 3 0
Suspected mixed ST infections (SMSI)a 9 13 0 11
a Mixed ST infections were suspected when double peaks were observed during sequence analysis.
Table 3
Statistical significance of difference between Blastocystis prevalence of
SEQ and Cambodian pigs and humans respectively.
Group tested Prevalence with
95% Confidence
Interval
2 test
Pigs
SEQ 184/240 (76.7%;
71.3, 82.0)
2 = 9.58, df = 1,
Cambodian 33/73 (45.2%; 33.8,
56.6)
p-value = 0.00196
Humans
SEQ 30/36 (83.3%; 71.2,
95.5)
2 = 10.1, df = 1,
Cambodian 116/210 (55.2%;
48.5, 62.0)
p-value = 0.0015
results of previous studies (Navarro et al., 2008; Yan et al.,
2007) which suggest that pigs are likely to be natural hosts
for Blastocystis ST5. All Blastocystis-positive pigs regardless
of geographical setting harboured ST5, the majority as sin-
gle infections. This is in agreement with previous smaller
scale studies (Alfellani et al., 2013c; Stensvold et al., 2009;
Yan et al., 2007; Yoshikawa et al., 2004), including a study
in Vietnam that reported 12/12 Blastocystis-positive pigs
tested for ST5. In China 16 pigs were identified as harbou-
ring ST5 only (Yan et al., 2007). In contrast, a large scale
study conducted in Valencia, Spain, found ST1 the predomi-
nant ST in intensively raised pigs (Navarro et al., 2008). This
variation of predominant STs (STs 1 or 5) found in pigs could
Table 4
Blastocystis prevalence and subtype distributions in SEQ and Cambodian
pigs (combined results of nested and ST-specific primers 1, 2, 3 and 5 PCR).
Subtype SEQ pigs (n = 240) Cambodian pigs
(n = 73)
% positive 76.7% (184) 45.2% (33)
5 only 167 20
1 and 5 6 0
2 0 0
3 and 5 4 0
1, 3 and 5 3 0
ST5 + unknown mixed STs 4 13
Note: All samples were tested with the nested PCR, but only samples with
ST1 (4) or ST3 (4) infections (identified with nested PCR) or SMSI (9) were
tested with ST-specific primers 1, 2, 3 and/or 5. As such, we  are unable to
rule out SMSI with other unidentified STs.
Test results of ST-specific 1, 2, 3 and/or 5 primers showed that: (1) all 4 ST1
and 4 ST3 infections (nested PCR) had mixed infections with ST5, (2) out of
9  SMSI (Table 2), 2 had mixed infections of STs 1/5, 3 with mixed infections
of  STs 1/3/5 and 4 had mixed infections of STs 5 and other unidentified
STs. We cannot exclude that these SMSIs involved other STs that were not
tested using additional ST-specific primers.
be attributed to geographical ST variation as observed in
non-human primates (NHPs) (Alfellani et al., 2013a). Here,
investigators identified STs 1, 2 and 3 infections in NHPs as
being independent of geographical association, while ST8
was primarily observed in species native to Asia or South
America (Alfellani et al., 2013a).
SEQ pigs had a significantly higher prevalence of Blas-
tocystis (76.7%) compared to pigs from Cambodia (45.2%).
A possible explanation could be that the intensively raised
SEQ pigs have a significantly higher rate of contact with
other pigs compared to the Cambodian pigs that are raised
singly or in small herds of up to four pigs in a small fenced
off area adjacent to village houses. Consequently, the risk
of faecal-oral transmission of Blastocystis is greater in the
SEQ pigs as compared to the Cambodia pigs.
In this study, the prevalence of Blastocystis in SEQ
intensive piggery staff (83.3%) was significantly higher
than Cambodian villagers (55.2%) (p < 0.05; Tables 3 and 5).
Although the prevalence of Blastocystis in humans is
generally higher in developing than developed countries,
prevalence can also vary within countries among different
subpopulations (Tan, 2008). The disparity in Blastocystis
prevalence between SEQ piggery staff and Cambodian
villagers may  be a reflection of animal handlers (piggery
staff) being at higher risk of acquiring zoonotic infections
(Driscoll, 2006; Mahdi and Ali, 2002; Murdoch, 2007),
including Blastocystis (Parkar et al., 2010; Rajah Salim
et al., 1999). Amongst the Cambodian villagers, only a neg-
ligible difference was observed between the prevalence of
Blastocystis amongst the pig-rearing villagers (55.5%) and
non pig-rearing villagers (54.7%), which is likely owing to
Table 5
Blastocystis prevalence and subtype distribution in SEQ piggery staff and
Cambodian villagers (combined results of nested and ST-specific primers
1,  2, 3 and 5 PCR).
Subtype SEQ staff (n = 36) Cambodian
villagers (n = 210)
% positive 83.3% (30) 55.2% (116)
1 only 11 33
2 only 0 27
3 only 14 45
5 only 3 0
3  and 5 2 0
SMSI (using nested PCR) 0 11
Note: The human samples were all tested with the nested PCR and ST5-
specific primers only. Eleven of the SMSI observed in the Cambodian
human mixed infections detected using nested PCR were not further
investigated. Test results of ST-specific 5 primers showed that 2 SEQ staff
with  ST3 infections (nested PCR) had mixed infections with ST5 and none
of  the Cambodian villagers had ST5.
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primarily anthroponotic transmission. The differences in
the prevalence of STs 1, 2 and 3 between pig-rearing and
non-pig rearing villagers were not statistically significant.
Subtypes 3 and 1 were most commonly detected in all
humans tested. This was followed by ST5 in 13.9% (5/36)
of the SEQ piggery staff and ST2 in 23.3% (27/116) of the
Cambodian villagers (Table 5). Although 2 SEQ staff were
found to carry mixed infections of STs 5 and 3, neither
ST5 nor mixed infections (with STs 1, 2, 3 and 5) were
detected in the Cambodian villagers (Table 5). ST distri-
bution studies conducted in various geographic regions
have demonstrated substantial geographical variation in
STs between populations (Alfellani et al., 2013b). In addi-
tion, they have also shown that humans may  carry STs 1–9
with ST3 being the most prevalent followed by STs 1, 2
and 4 and that ST2 is commonly reported in certain areas
such as Brazil, Europe and Central Asia (Alfellani et al.,
2013b). Our results are in agreement with these findings
and endorse the presence of ST2 as common in humans
in rural Cambodia. In our study, all human samples were
tested with the pan-ST nested PCR and the ST5 specific
primers only and these identified STs 1, 2, 3 and 5. Other STs
such as STs 4, 6, 7 and 8 have also been reported in Australia
and/or Southeast Asia (Alfellani et al., 2013b; Nagel et al.,
2012), however these additional STs were not specifically
tested for with ST-specific primers in this study and their
presence could therefore not be excluded.
Comparison of the 606 bp and 403 bp nested PCR prod-
uct regions of the SSU rRNA of ST1 andST3 from pigs and
humans respectively, revealed 100% sequence identity for
all three STs regardless of host and geographical location.
Comparison of a 477 bp region of the nested PCR product
of the SSU rDNA of ST5 also revealed 100% identity, with
the exception of a single nucleotide polymorphism (with
either adenine or thymine) at 398 bp (GenBank accession
no. KJ082062) that was shown to be independent of host
and geographical location. This suggests that the SEQ pigs
and piggery staff in this study carried very similar Blas-
tocystis STs 1, 3 and 5, which may  have been transmitted
between these hosts within their environment.
Despite ST5 being rarely reported in humans, 13.9%
(5/36) of SEQ piggery staff harboured identical STs to in-
contact pigs, suggesting that these piggery workers may
have acquired the infection from intensively raised pigs.
Piggery staff members are repeatedly exposed to large
amounts of pig faeces during cleaning of high density pig
pens. High pressured water hoses cause aerosolisation of
faeces and potentially increase risk of faecal-oral trans-
mission. In contrast, Cambodian villagers that live in close
proximity with the pigs they rear did not harbour ST5
despite a Blastocystis prevalence of 45.2% in pigs. This is
likely due to the less intensive nature of pig rearing in
Cambodian villages, where each household rears a max-
imum of 4 pigs confined to small areas adjacent to or
beneath the house. To further investigate this hypothe-
sis, future work should include testing a greater number
of piggery staff as well as a control group of piggery staff
that do not have direct contact with pigs (e.g. adminis-
trative staff) together with non-piggery workers from the
same geographical area. Comparison of the SEQ human and
pig Blastocystis isolates characterised in this study using a
MLST approach would add further evidence for the para-
site’s potentially zoonotic abilities; however, this approach
has not yet been developed for ST5.
A minority of SEQ pigs were found to harbour mixed
infections with ST5 and ST1 (n = 9) and/or ST3 (n = 9), which
were not observed in Cambodian pigs using both nested
and ST-specific PCR. Comparison of the pig and human
ST1 and ST3 sequences showed 100% identity, respectively.
Subtype 3 has been reported in pigs but is uncommon
(Abe et al., 2003; Stensvold et al., 2009; Yoshikawa et al.,
2004), whilst ST1 is common in pigs in certain subpopula-
tions such as commercial piggeries in Valencia, Spain and
pigs kept at an army base in Chonburi, Thailand (Navarro
et al., 2008; Thathaisong et al., 2003). Given that ST5 was
the predominant ST in pigs from SEQ and that the piggery
staff predominantly harboured STs 1 or 3, there is a pos-
sibility that the SEQ pigs harbouring STs 1 or 3 may have
acquired the Blastocystis infection from human handlers.
In other words, this could be a reverse zoonosis, though
MLST of isolates would be required to further confirm this
hypothesis.
4. Conclusion
The results of the study support the hypothesis that pigs
are natural hosts of Blastocystis due to the high prevalence
in different geographical localities and predominant infec-
tion with ST5 which has been proposed as a pig-adapted
ST. There was  a concurrent high prevalence of Blastocystis
in both SEQ piggery staff and Cambodian villagers with STs
1 and 3 being the most predominant STs in both regions.
In addition, ST2 was  detected in the Cambodian villagers.
These findings could reflect geographical variation or iso-
lation among certain STs. The study also indicated the
proposed pig-adapted ST5 may  be a zoonosis as 13.9% of
SEQ piggery staff harboured ST5 which is otherwise con-
sidered rare in humans. Piggery staff are most likely to
have acquired ST5 infection through close contact with pig
faeces while carrying out daily routines. In addition, the
presence of STs 1 and/or 3 in a minority of SEQ pigs in
addition to piggery staff could indicate reverse zoonotic
transmission.
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pathogenic potential of Blastocystis in the porcine intestine. PLoS One 9, e103962. 
 
In the preceding study, we demonstrated that pigs in SEQ and Cambodia had a high prevalence of 
Blastocystis with a majority of pigs harbouring ST5 (Wang et al., 2014c). Interestingly, a minority 
of pigs harboured ST1 and/or ST3, which are common in humans, while a minority of SEQ piggery 
staff harboured ST5, which is rarely reported in humans (Wang et al., 2014c).  Collectively we 
found that pigs are likely to be natural hosts of Blastocystis with a presumed host-adapted ST (ST5) 
and are able to harbour STs in common with humans, and that both reverse (STs 1 and 3) and direct 
zoonotic transmission (ST5) of Blastocystis may occur between humans and pigs (Wang et al., 
2014c). We hypothesised that pigs may indeed be suitable for animal model development for 
blastocystosis. 
 
In this study, we aimed to further characterise the host-parasite relationship by attempting to 
localise Blastocystis organisms/DNA within the porcine intestine using light microscopy and PCR 
on intestinal material and mucosal scrapings. We also used histology to examine for any organic 
pathology associated with infection. Intestine from pigs reared in three different management 
settings were examined, namely from an intensive piggery, small scale family farm and a research 
facility (where pigs were immunosuppressed with oral dexamethasone). The study was designed to 
determine if environment or immune status played a role in intestinal colonisation of Blastocystis.  
 
 
 
  
Location and Pathogenic Potential of Blastocystis in the
Porcine Intestine
Wenqi Wang1*, Helle Bielefeldt-Ohmann1,2, Rebecca J. Traub3, Leigh Cuttell1, Helen Owen1
1 School of Veterinary Science, The University of Queensland, Gatton, Queensland, Australia, 2Australian Infectious Diseases Research Centre, The University of
Queensland, St. Lucia, Queensland, Australia, 3 Faculty of Veterinary Science, The University of Melbourne, Parkville, Victoria, Australia
Abstract
Blastocystis is an ubiquitous, enteric protozoan of humans and many other species. Human infection has been associated
with gastrointestinal disease such as irritable bowel syndrome, however, this remains unproven. A relevant animal model is
needed to investigate the pathogenesis/pathogenicity of Blastocystis. We concluded previously that pigs are likely natural
hosts of Blastocystis with a potentially zoonotic, host-adapted subtype (ST), ST5, and may make suitable animal models. In
this study, we aimed to characterise the host-agent interaction of Blastocystis and the pig, including localising Blastocystis in
porcine intestine using microscopy, PCR and histopathological examination of tissues. Intestines from pigs in three different
management systems, i.e., a commercial piggery, a small family farm and a research herd (where the animals were
immunosuppressed) were examined. This design was used to determine if environment or immune status influences
intestinal colonisation of Blastocystis as immunocompromised individuals may potentially be more susceptible to
blastocystosis and development of associated clinical signs. Intestines from all 28 pigs were positive for Blastocystis with all
pigs harbouring ST5. In addition, the farm pigs had mixed infections with STs 1 and/or 3. Blastocystis organisms/DNA were
predominantly found in the large intestine but were also detected in the small intestine of the immunosuppressed and
some of the farm pigs, suggesting that immunosuppression and/or husbandry factors may influence Blastocystis
colonisation of the small intestine. No obvious pathology was observed in the histological sections. Blastocystis was present
as vacuolar/granular forms and these were found within luminal material or in close proximity to epithelial cells, with no
evidence of attachment or invasion. These results concur with most human studies, in which Blastocystis is predominantly
found in the large intestine in the absence of significant organic pathology. Our findings also support the use of pigs as
animal models and may have implications for blastocystosis diagnosis/treatment.
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Introduction
Blastocystis is an ubiquitous, intestinal protozoan that was first
described by A. Alexieff in 1911, and subsequently found to infect
a variety of hosts including humans and many animal species [1–
4]. A century later, it still remains an enigmatic organism with
controversy over its life cycle and most importantly, pathogenicity.
In humans, the association between Blastocystis infection and
gastrointestinal disease remains controversial [4]. A relationship
with irritable bowel syndrome (IBS) has been suggested in several
studies [5–8], often based on a higher Blastocystis prevalence in
IBS patients compared to control groups. The proposed mecha-
nism of Blastocystis-associated IBS is low grade inflammation of
the mucosa, which is well recognised in IBS patients, associated
with persistent Blastocystis infection and antigenic stimulation [7].
However, more extensive, controlled studies need to be conducted
to clearly define the role of Blastocystis, if any, in gastrointestinal
disease and IBS [7].
In recent years, intestinal protozoa have been shown to cause
increased morbidity and mortality in immunocompromised hosts
(e.g. human immunodeficiency virus (HIV) patients, transplant
patients, immunocompromised children) [9–11]. A link between
immunosuppression and blastocystosis has been proposed, with
immunocompromised individuals, such as patients infected with
HIV, cancer patients, renal transplant patients and children,
potentially being more susceptible to infection and associated
clinical signs [4,10,12–14]. We speculate that Blastocystis could be
an opportunistic, gastrointestinal pathogen and that immunosup-
pression may be an important predisposing factor for disease
development.
One of the major obstacles to understanding the pathogenicity
of the organism and the pathogenesis of blastocystosis is the lack of
an established animal model to fulfil Koch’s postulates [4,7,15].
Experimental infections have been conducted in guinea pigs, mice,
chickens and rats with conflicting results on pathogenic potential
of Blastocystis. Mild pathology and self-limiting disease has been
observed in mice, while moderate to severe pathology has been
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observed in some chickens and rats with various Blastocystis
isolates [16–19]. Reported histopathological findings in these
animal infectivity studies include inflammation, mucosal sloughing
and mild lamina propria oedema. Blastocystis organisms were
usually found in luminal material or at the epithelial edge in the
caecum and colon of infected mice [17]. To date, conclusive
evidence of Blastocystis-associated histopathology in human
intestine is lacking, therefore, most of these animal models are
unlikely to be representative of host-adapted subtype (ST) infection
in a human host.
In a previous study we reported a high prevalence of Blastocystis
carriage in pigs (up to 76.7%) with all pigs harbouring ST5 and a
small proportion of pigs harbouring STs 1 and/or 3 [20]. Based
on these results, we concluded that pigs are likely to be a natural
host of Blastocystis with ST5 being the host adapted ST [20]. In
addition, they are able to harbour STs 1 and 3, the two most
commonly reported STs in humans [1], and therefore may be
suitable candidates for animal model development.
The first aim of the current study was to localise Blastocystis in
the intestinal tract of pigs. While Blastocystis has been demon-
strated in the caecum and colon in animal infectivity studies
[17,18], there have been no definitive reports of site predilection in
humans. Secondly, we aimed to assess porcine intestine for any
colonisation associated histopathology and compare with the
human paradigm where significant organic pathology is usually
not identified. Lastly, we aimed to determine if immune status
and/or environmental factors influence the pathogenicity of
Blastocystis in pigs.
Materials and Methods
Sampling
Intestinal samples were collected during post-mortem examina-
tion of 28 pigs from three locations in Southeast Queensland,
Australia: 1) 12 healthy pigs from a small family farm, 2) 11 pigs
from a commercial intensive piggery (6 weaners and 5 growers/
sows) and, 3) five grower pigs from a research facility. The research
pigs were originally obtained as piglets from the commercial
piggery before being transferred to the research facility where they
were early weaned at three weeks and treated daily with 0.25 mg/
kg of oral Dexamethasone until 16 weeks of age to induce
immunosuppression. These research pigs were fed on a commer-
cial diet with no added antibiotics. Commercial pigs were given an
amoxycillin injection at weaning (4 weeks of age) and transferred
to a commercial feed which differed from that given to the
research pigs. Feed for the commercial pigs was medicated with
olaquindox till 9 weeks of age. From 9 weeks onwards, antibiotics
were given only when animals were ill. This indicates that the 6
commercial weaners were on antibiotics whilst the 5 commercial
growers/sows were not.
Post-mortem samples were collected after the pigs had either
died of causes unrelated to the gastrointestinal tract (e.g.
neurological signs, sudden death) or were healthy pigs that were
slaughtered at the Brisbane Valley Meats abattoir (Queensland,
Australia) or euthanised after unrelated research or teaching use.
Samples were collected at a maximum of 12 hours following death
with the carcass being refrigerated for the interval between death
and sampling to minimise autolysis.
A variety of samples were collected from the three sections of
small intestine, namely duodenum, jejunum and ileum and three
sections of large intestine, namely caecum, colon and rectum
(Table 1). Samples collected from each intestinal segment included
luminal contents, mucosal scrapings and cross sectional tissue
biopsies. For mucosal scraping collection, segments of mucosa
were first rinsed gently in phosphate buffered saline (PBS) twice
and scrapings were taken by gently scraping the washed mucosal
surface with a scalpel blade till the top layer dislodged. Luminal
contents and mucosal scrapings were stored in individual 50 ml
sterile plastic containers and 2 ml microcentrifuge tubes, respec-
tively, at room temperature and processed within 6 hours of
collection. Biopsy samples were stored in 10% buffered formalin at
room temperature for at least 48 hours before processing.
Faecal wet mount and xenic in-vitro culture (XIVC)
Fresh luminal material was added to distilled water to make a
faecal wet mount and examined for Blastocystis organisms using
light microscopy. For XIVC, approximately 1–2 grams of luminal
material was incubated with 10 ml of Jones’ culture medium
enriched with 10% heat-inactivated horse serum (Gibco,
26050088, Life Technologies, USA) at 37uC under aerobic
conditions for 24–48 hours and examined using light microscopy
[21,22].
Molecular analysis
i. DNA extraction. DNA was extracted from fresh luminal
material, culture material and mucosal scrapings using QIAamp
DNA Stool Mini Kit (Qiagen Germany), as previously described
[23].
ii. PCR amplification with nested PCR primers. Samples
were initially tested with a published pan-Blastocystis nested PCR
primer set and conditions, amplifying a 1100 bp region of the
Blastocystis 18S ribosomal small subunit RNA gene (18S SSU
rRNA gene) [24,25]. Each 25 ml PCR reaction was run with
approximately 50 ng of DNA.
iii. Phylogenetic analysis to subtype Blastocystis
isolates. PCR products of samples positive with the nested
PCR were purified with the PureLink Genomic DNA Mini Kit
(Life Technologies Corporation, New York, USA) according to the
manufacturer’s protocol. Using an Applied Biosystems 3130/
3130xl Genetic Analyzer, unidirectional DNA sequencing was
Table 1. Samples collected and tests carried out from each segment of porcine intestine.
Sample collected
Technique Luminal contents Mucosa scraping Tissue biopsy
Light microscopy (faecal wet mount) X X
Xenic in-vitro culture* X
PCR X (+ culture material) X
Histopathology X
doi:10.1371/journal.pone.0103962.t001
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performed on purified products using the reverse primer of the
secondary PCR. The sequences were then analysed using Finch
TV v 1.4.0 (Geospiza Inc., Seattle, WA, USA) and compared with
published sequences from GenBank (National Center for Biotech-
nology Information) using BLAST 2.2.9 (http://blast.ncbi.nlm.
nih.gov/Blast.cgi). Utilising Bioedit c 7.1.3.0 software (Ibis
Biosciences, Carlsbad, CA, USA), these sequences were aligned
with published sequences of the 18S SSU rRNA gene of the
various Blastocystis STs, which were sourced from GenBank. The
aligned sequences were then analysed using Mega 4.1 software
(The Biodesign Institute, Tempe, AZ, USA) to construct a
neighbour joining tree, with Proteromonas lacerate (U37108) as
an out-group. This was performed to subtype the Blastocystis
isolates.
iv. PCR amplification with ST-specific
primers. Published subtype-specific (ST-specific) primers for
STs 1, 3 and 5 were used to test samples with suspected mixed ST
infections as these STs were previously observed in this population
of pigs and in-contact humans [20]. These suspected mixed ST
infections were identified using the nested PCR described above
(i.e., double peaks observed during sequence analysis). Each of
these ST-specific primers was designed to amplify partial segments
of the 18S SSU rRNA gene of Blastocystis.
Histopathological analysis of biopsies
Cross-sectional tissue biopsies were taken from each intestinal
segment and fixed in 10% buffered formalin for at least 48 hours.
Only segments positive by PCR were processed for histological
analysis. Tissue sections were cut at 5 mm, stained with
haematoxylin and eosin and examined using light microscopy.
Slides were examined for presence and location of Blastocystis in
the mucosa, evidence of mucosal damage, inflammation or
increased numbers of infiltrating leucocytes in the mucosa or
any other associated pathology. The leucocyte population in the
lamina propria was characterised by determining average number
and type of leucocytes between the intestinal crypts (e.g.,
lymphocytes, plasma cells, neutrophils, eosinophils etc.) (Figure 1,
grading scheme). The grading scheme was based on a grading
scheme developed for dog and cat intestinal biopsies [26]. Each
pig was given an average histological grade for small and large
intestine, respectively, by summing up the grade for the three
segments (if applicable) in large or small intestine. As controls,
several PCR negative small and large intestine samples were used
for comparison.
Statistical analysis
Statistical analysis was carried out using either the program
WINPEPI [27] or an online program http://quantpsy.org [28].
These two programs were used to perform Pearson’s chi-squared
tests to: 1) determine if any ST was associated with any particular
intestinal segment [28] and 2) compare the probability of pigs from
each of the three different groups having Blastocystis in the small
intestine [27].
Ethics statement
This project was approved by the University of Queensland
Animal Ethics Committee and Medical Research Ethics Commit-
tee with approval no. ANRFA/SVS/347/12.
Results and Discussion
Molecular detection and localisation of Blastocystis
All (28/28) pigs, regardless of origin, were positive for
Blastocystis by microscopy and PCR and all animals harboured
ST5 (Table 2). Pigs from the commercial piggeries and research
facility harboured ST5 only (Table 3). In contrast, 7/12 (58%) of
the pigs from the small scale farm had mixed infections of ST5 and
ST1 and/or 3, with the remaining 5 harbouring ST5 only
(Table 3). The STs found in this cohort of pigs corresponded to
those found in our previous study [20]. All pigs were consistently
found to harbour Blastocystis in the large intestine by XIVC and
PCR of faecal and cultured material, with Blastocystis being found
in all the colons and approximately 90% of the caeca and rectums
examined (Table 3). Analysis using Pearson’s chi-squared tests
demonstrated that no ST was significantly associated with a
particular intestinal location (p-value for ST1, ST3 and ST5
respectively were .0.05) [28]. Our results concur with several
other studies, including a study on naturally infected pigs where
Blastocystis was mainly found in the caecum and colon using
immunofluorescence assay (IFA) in combination with PCR [29].
Previous experimental animal infectivity studies also found
Blastocystis mainly in the caecum and colon of mice, guinea pigs
and rats; however some of these animals had undergone
intracaecal inoculation with Blastocystis [17–19]. This finding
supports the potential link between IBS and Blastocystis as IBS is
considered a condition that affects the large bowel/colon.
In contrast, Blastocystis DNA was detected within the small
intestine in only 36% (10/28) of the pigs (Table 2, 3). Of these 10
pigs, 1 (9.1%) was from a commercial piggery, 4 (33.3%) from the
small scale piggery and the remaining 5 (100%) were immuno-
Figure 1. Grading scheme for quantifying leucocytes in lamina propria of porcine intestine. Haematoxylin and eosin (10X) (A) low: 1–
3 leucocytes between crypts, (B) medium: 3 to 5 leucocytes between crypts, (C) high: .5 leucocytes between crypts.
doi:10.1371/journal.pone.0103962.g001
Table 2. Frequency of detection of Blastocystis in porcine intestinal segments using PCR (nested and ST-specific primers) in small
versus large intestine.
Intestinal Section
Farm Small and large intestine Large intestine only
Commercial (11) 1 10
Research (5) 5 0
Small family farm (12) 4 8
Total no. of pigs (28) 10 18
doi:10.1371/journal.pone.0103962.t002
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suppressed research pigs (Table 3). Statistical comparison of
different environmental settings showed that immunosuppressed
research pigs were much more likely to have Blastocystis DNA
detected in the small intestine as compared to the commercial and
farm pigs respectively (Table 4; p-value =,0.05, odds ra-
tio = 0.00, reciprocal ‘). In the research pigs, Blastocystis DNA
was not detected in the duodenum, however it was found in the
jejunum of 3/5 animals and in the ileum of 5/5 pigs (Table 3).
Reported effects of immunosuppression on the gastrointestinal
(GIT) system include loss of gastric acidity, impaired/deficient T
cell mediated immune response, reduced mucosal integrity and
impaired mucosal regeneration [10,30]. Impaired T cell immune
response has been shown to facilitate infection of the immuno-
compromised host with intestinal protozoa, however ultimately the
pathogenesis within the host is not clearly understood [10]. It is
possible that the dexamethasone-induced immunosuppression in
these pigs had led to functional pathology such as a dysregulated T
cell-mediated immune response [31,32]. These effects may then
allow Blastocystis to colonise not only the usual locations in the
large intestine but to also ascend into the distal sections of the
small intestine, where it could have a different interaction with the
host and potentially cause disease (opportunistic infection). It
should be noted that in this study we were unable to evaluate the
immune system of the dexamethasone-treated pigs. However,
these pigs were used primarily for a project investigating the
immunopathology of scabies. The pilot study of this scabies project
showed that using the above mentioned dexamethasone regime,
dexamethasone-treated mange infected pigs were more likely to be
chronically infected as compared to untreated pigs that had no/
few mites and symptoms that resolved within 6 weeks [33]. Given
that all the commercial pigs, regardless of age and antibiotic
regime, had Blastocystis predominantly in the large but not small
intestine, it is unlikely that the antibiotics had any effect on
location of Blastocystis colonisation in the porcine intestine.
Amongst the 10 pigs in which Blastocystis DNA was detected in
the small intestine, 4/10, 5/10 and 7/10 had Blastocystis DNA in
the duodenum, jejunum and ileum contents respectively. This is in
contrast to the study by Fayer et al. [29], where Blastocystis was
not detected in the ileum, jejunum and duodenum contents using
PCR and IFA, and was only detected in small numbers in the
jejunum tissue using IFA. The discrepancy between the results of
the current study and those of Fayer et al. [29] could be due to a
number of factors that could influence sensitivity of detection.
These include different samples tested such as cultured material
and mucosal scrapings, different diagnostic techniques and PCR
primers used (nested PCR and STS primers) which could better
sensitivity of detection. This would be especially likely if only few
organisms/small amounts of DNA were present in the small
intestine, as also suggested by Fayer et al. [29]. Alternatively, the
different environmental and housing conditions of the pigs (e.g.,
immunosuppressed pigs, diet) may have an influence on small
intestine survival/colonisation of Blastocystis.
In this study, PCR of cultured material was the most sensitive
method of Blastocystis detection. Setting this method as a gold
standard, the sensitivities of XIVC, PCR of luminal material
DNA, a wet faecal smear and PCR of mucosal scrapings were
81.3%, 58.5%, 45% and 32.5% respectively. PCR is widely
recognised as the gold standard for Blastocystis diagnosis and
XIVC has almost comparable sensitivity [22,34–36]. We found
combining the two techniques in series (amplification of small
numbers of Blastocystis from luminal material using XIVC
followed by PCR) the most sensitive method for detection. Ideally,
a larger sample size would allow for more accurate establishment
of sensitivity.
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In the small intestine of the commercial and small scale piggery
pigs, Blastocystis DNA was detected mostly in cultured material,
whereas in the research pigs it was detected in faeces in 3/5 pigs
and in cultured material in 5/5 of the pigs. Taking into account
that PCR of cultured material is the most sensitive detection
method and the PCR results (Table 2, 3), we speculate that there is
generally a lower number of Blastocystis organisms/DNA in the
small intestine as compared to the large intestine. The low
sensitivity of PCR on mucosal scrapings could be due to
Blastocystis having no or weak attachment to the epithelium
and/or due to prior rigorous rinsing of the surface with PBS.
Histopathology
In the intestinal histological sections examined, granular or
vacuolar forms of Blastocystis organisms were often observed
either within the luminal material or at the tip of the epithelium,
but there was no evidence of attachment or invasion of the
epithelium (Figure 2). The organisms were most commonly
identified in the caecum and colon histological sections, which
corresponded to the PCR results. There was no associated
pathology such as frank inflammation, epithelial damage, mucosal
sloughing or lamina propria oedema as has been described
previously in experimental animal infectivity models [17,18,37].
This lack of pathology was also observed in the preceding study on
naturally infected pigs [29]. Comparison of histological grading of
PCR positive small and large intestinal histological sections with
the negatives did not demonstrate any large differences in grade
(Table 5). Both Blastocystis positive and negative groups of pigs
had histological grades that ranged from low to low/medium to
medium, as such we cannot confidently identify any increase in
inflammatory cells associated with Blastocystis carriage (Table 5).
Amoeboid forms that have been suggested to be pathogenic [38]
were not observed in the asymptomatic pigs in this study.
In this study, the lack of organic pathology in Blastocystis-
infected porcine intestine concurs with a study in naturally infected
pigs [29] and the majority of the earlier human studies, with the
exception of 2 case studies. Both patients had ulcerative colitis with
associated superficial colonisation by Blastocystis organisms
[39,40]. This invasive behaviour is likely the result of the
underlying ulcers allowing for opportunistic, superficial colonisa-
tion of Blastocystis. Although Blastocystis has been linked to certain
intestinal conditions such as ulcerative colitis and haemorrhagic
proctosigmoiditis, no histological evidence of Blastocystis causing
primary intestinal damage has been demonstrated [41–43].
Conclusions
We propose pigs as suitable animal models for Blastocystis as
they are natural hosts of Blastocystis, with a host adapted ST
(ST5), and are able to harbour ST1 and ST3 which are frequently
found in humans. Pigs harbour Blastocystis predominantly in the
large intestine, as detected by molecular and histological methods,
which is in agreement with previous animal infectivity studies.
Occasionally, Blastocystis was detected in the small intestine,
notably in the immunosuppressed research pigs, which suggests
that immunosuppression may alter host-agent relations and
predispose to small intestinal colonisation. Lastly, histological
analysis of PCR-positive porcine intestine revealed no evidence of
pathology caused by Blastocystis which is consistent with the
majority of human studies. Alternatively, we could speculate that
Blastocystis may cause clinical disease via other mechanisms such
as host immune modulation or disruption of the epithelial barrier,
perhaps in synergism with unknown pathogens or opportunists. In
the future, all these aspects can be readily studied in the pig model.
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Table 4. Chi-Square analysis of proportion of pigs in each farm setting with Blastocystis DNA detected in the small intestine.
Farm
Pearson’s Chi Square
value (x2) p-value Odds ratio (95% C.I)
Commercial vs1 Research x2 = 12.121; 0.000 0, reciprocal ‘ (95% C.I. = 0.00 to 0.33)
Small family farm vs Research x2 = 6.296; 0.012 0, reciprocal ‘ (95% C.I. = 0.00 to 0.92)
Commercial vs Small family farm x2 = 1.982; 0.159 0.2, reciprocal 5.00 (95% C.I. = 0.00 to 2.75)
1vs-versus.
doi:10.1371/journal.pone.0103962.t004
Table 5. Average intestinal histological grade for Blastocystis positive porcine large intestinal sections in each piggery setting.
Histological grade
Farm Low Low/medium Medium Medium/high High
Commercial (11) 7 1 1 1 1
Small family farm (12) - 4 3 3 2
Research (5) - 5 - - -
Total (28) 7 10 4 3 3
The average histological grade for the small intestinal sections in which Blastocystis was detected was either low/medium. The average histological grade for the PCR
negative control sections for small and large intestine were medium and low/medium respectively.
doi:10.1371/journal.pone.0103962.t005
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In the porcine intestinal study, we identified Blastocystis DNA/organisms predominantly in the 
large intestine of all (28/28) the pigs tested, however there was no evidence of any organic 
pathology associated with infection (Wang et al., 2014a). These findings correspond to what has 
been mainly reported up till now in human blastocystosis patients. Interestingly, all (5/5) of the 
immunosuppressed research pigs and some of the family farm pigs harboured Blastocystis in the 
small intestine as well (Wang et al., 2014a). This raised the suspicion that immunosuppression or 
certain environmental factors may play a role in small intestinal colonisation of Blastocystis, which 
may in turn be linked to its pathogenesis or clinical significance (Wang et al., 2014a). The absence 
of any organic pathology led us to deduce that Blastocystis could be causing disease via other 
mechanisms such as immunomodulation. This led us to our final study to attempt to characterise the 
Blastocytis specific IgA immune response in pigs. Secretory IgA was specifically chosen as it is the 
most abundant immunoglobulin and is the first line of defense against adherence and invasion by 
enteric pathogens (Macpherson et al., 2008). 
 
  
Characterization of the Blastocystis-specific faecal IgA immune
response in pigs
W. WANG,1 L. CUTTELL,1 R. J. TRAUB,2 H. OWEN1 & H. BIELEFELDT-OHMANN1,3
1School of Veterinary Science, The University of Queensland, Gatton, Qld, Australia, 2Faculty of Veterinary Science, The University of
Melbourne, Parkville, Vic, Australia, 3Australian Infectious Diseases Centre, The University of Queensland, St. Lucia, Qld, Australia
SUMMARY
Blastocystis is an intestinal protist found in many species
including humans and pigs. It has a controversial pathogene-
sis and has been implicated as a potential cause of irritable
bowel syndrome. Our previous studies identified pigs as
potential animal models for blastocystosis by demonstrating
that they were likely natural hosts of Blastocystis and can
harbour subtypes (ST) in common with humans. Further-
more, our finding of a lack of intestinal histopathology asso-
ciated with Blastocystis infection in pigs is also a consistent
finding in examined infected humans. In this study, we
aimed to identify and characterize the Blastocystis-specific
mucosal IgA response in pigs by immunoblotting, using pig
faecal antibodies and Blastocystis antigen. Faeces from 233
pigs representing three age groups (sows/boars, growers/
weaners and piglets) and including five dexamethasone-im-
munosuppressed research pigs were tested. The majority
(815%) of the pigs had faecal IgA reactivity against
Blastocystis proteins of molecular weights of 175–120 kDa.
Reactivity to a >250 kDa protein was found in 185% of
pigs. Notably, immunosuppressed pigs and piglets were
statistically more likely to have reactivity to this protein
compared to growers/weaners and sows/boars, respectively.
These results corroborate other findings suggesting that
compromised immunity may predispose to blastocystosis and
support our contention that pigs are potentially good models
for pathogenesis studies.
Keywords animal model, antibody, Blastocystis, immune
response, immunosuppression, pig
INTRODUCTION
Blastocystis is an intestinal protist that is frequently
reported in humans and many other species, including pigs
(1, 2). Although it was first described in 1911, its pathoge-
nicity and pathogenesis remain poorly understood largely
due to absence of a representative animal model of infec-
tion (3). In our previous studies, we have shown that pigs
may represent a suitable animal model for blastocystosis
investigations based on: (i) a high prevalence of Blastocys-
tis in pigs in diverse geographical regions, with ST5 being
the predominant and potentially a host-adapted ST, (ii) a
minority of pigs harbour ST1 and/or ST3, which are the
two most frequently reported STs in humans (4), (iii)
Blastocystis is predominantly located in porcine large
intestine, with no evidence of any organic pathology and
epithelial invasion by Blastocystis, which is consistent with
findings in the majority of human patients examined so
far, (iv) immunosuppressed pigs are more likely to have
Blastocystis in both the small and large intestine, suggest-
ing that immunosuppression may predispose to small
intestinal colonization of Blastocystis (5). Our hypothesis
is that the lack of intestinal histopathology does not
negate pathogenic potential of Blastocystis, but rather clin-
ical symptoms could be caused by other mechanisms as
suggested by in vitro Blastocystis studies (6–10). These
include, but are not necessarily limited to, upregulation of
proinflammtory cytokines such as IL-6 and IL-8, func-
tional disruption of the epithelial barrier and host immu-
nomodulation (6–10).
The majority of Blastocystis pathogenicity studies are
based on in vitro work, and there is a paucity of serologi-
cal information available regarding the immune response
to infection. Of the few serological studies conducted,
there have been conflicting results. Zierdt et al. (11)
reported a Blastocystis-specific IgG serum response in 25
of 28 symptomatic humans, but no observable serum IgA
response. In contrast, Mahmoud & Saleh (12) reported
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significantly higher levels of both anti-Blastocystis faecal
and serum IgA and IgG in symptomatic blastocystosis
patients (i.e. gastrointestinal symptoms) compared to
asymptomatic patients. The authors also observed a higher
faecal and serum IgA response in the symptomatic
patients, with IgA levels being higher in faeces than serum.
Santos & Rivera (13) studied the serum and intestinal
immune response in Blastocystis immunized Balb/C mice
over 8 weeks and found high serum IgM levels in the early
stages of infection while IgA was the predominant anti-
body in intestinal secretions. In these last two mentioned
studies, it was hypothesized that there is preferential stim-
ulation of mucosal IgA by Blastocystis antigen as com-
pared to serum IgA, which is likely due to secretory IgA
being the most abundant immunoglobulin and the first
line of defence against adherence and invasion by enteric
pathogens (12, 13). It appears that IgA, especially intesti-
nal secretory IgA, may play an important role in the
immune response against Blastocystis.
Based on our previous studies, we have identified the
pig as a potential candidate for blastocystosis studies and
that immunomodulation/immunosuppression may play a
role in the pathogenicity of Blastocystis (4, 5). The aim of
this study was to characterize the protein profile of the
Blastocystis-specific IgA faecal immune response in a pre-
viously studied population of Southeast Queensland pigs,
utilizing the immunoblotting technique and lysates of axe-
nically grown Blastocystis. These pigs had been previously
tested by PCR for the presence of Blastocystis (3). We
chose to investigate the IgA response specifically as: (i) its
production in mammals is higher than for other immuno-
globulin isotypes, (ii) it is exported across the gastrointesti-
nal mucous membranes and (iii) it dominates humoral
mucosal immunity (14).
MATERIALS AND METHODS
Sampling
Single-faecal samples were collected from 233 asymptom-
atic pigs of three different age groups from 16 commercial
piggeries and a research facility. The faecal samples were
collected off the ground shortly after the pigs had defe-
cated. The samples were obtained from four different
groups, namely 130 sows/boars, 68 growers/weaners, 30
piglets and five experimentally immunosuppressed grower
pigs from a research facility. Between two and 23, individ-
ual samples were collected from each commercial piggery
and five samples from the research facility. The five
research pigs had been treated with low-dose dexametha-
sone per os from 3 to 16 weeks of age to induce immuno-
suppression for a study unrelated to this work. All faecal
samples were frozen at 20°C until analysis. All samples
had previously been tested by PCR using a nested PCR
and selected ST-specific primers for Blastocystis (3). Of
the 233 samples, 164 (704%) were PCR positive and 69
(296%) were PCR negative. Of the 164 PCR-positive sam-
ples, 13 (79%) harboured mixed infections of ST5 and
ST1 and/or ST3 and the remainder harboured ST5 only
(3).
Sample processing
The technique for extracting faecal antibodies was modi-
fied from Santiago et al. (15). Thawed faecal samples were
suspended in three times the volume of phosphate-buffered
saline (PBS) with 005% (wt/vol) Tween 20 (PBS-T). The
faecal PBS-T mixture was mixed thoroughly by vortexing
and then centrifuged at 12 300 g for 25 min to pellet the
solid debris. The supernatant was then transferred into
new 15-mL microcentrifuge tubes and centrifuged at
4000 g for 10 min to further remove solid debris. The
remaining supernatant was kept frozen at 20°C until
analysis.
Antigen preparation for immunoblot analysis
Antigen for the immunoblot was obtained from axenic
cultures of a Blastocystis ST4 isolate, WR1, originally iso-
lated from rats housed in the National University of Sin-
gapores Animal Holding Unit (16). The axenic cultures
were maintained at 37°C in pre-reduced Iscoves modified
Dulbeccos medium (Sigma-Aldrich, Grand Island, MO,
USA) enriched with 10% heat-inactivated horse serum
(Gibco, NY, USA). Protein was extracted from Blastocys-
tis organisms using Complete Lysis-B kit (Roche Diagnos-
tics, Basel, Switzerland) as per the manufacturers
protocol, and the liquid suspension of antigen was frozen
at 20°C until further use.
Detection of faecal antibodies by immunoblot analysis
Approximately 300 ng of Blastocystis protein was loaded
with an equal volume of loading buffer onto 4–15% Mini-
PROTEAN TGXTM gels (Bio-Rad, Hercules, CA, USA)
and electrophoresed in 1X Tris/Glycine/SDS buffer (Bio-
Rad) at 100V for approximately 1 h. The loading buffer
was made up of Laemmli sample buffer (Bio-Rad) and 2-
betamercaptoethanol (Bio-Rad) in a ratio of 19 : 1
(vol : vol). The proteins were subsequently transferred to a
nitrocellulose membrane in 1 X Tris/Glycine buffer
(Bio-Rad) at 4°C, at 100V for 1 h and cut into strips.
The nitrocellulose membrane strips were blocked in
25% casein in PBS-T for 1 h at room temperature (RT)
504 © 2014 John Wiley & Sons Ltd, Parasite Immunology, 36, 503–508
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and then incubated with 2 mL of faecal antibody extract
overnight on a rocker platform at 4°C. Membrane strips
were then washed with PBS-T for three consecutive
20-min wash steps and then incubated with horseradish
peroxidase (HRP)-conjugated goat anti-pig IgA H&L
(Abcam, Cambridge, UK) diluted at 1 : 1000 with PBS-T
on a rocker platform at RT for 1 h. Membrane strips were
then washed as per above and developed using Clarity
Western ECL Substrate (Bio-Rad) and visualized using a
Bio-Rad ChemiDocTM XRS Gel Documentation system.
Controls
The internal positive control used for all batches was a
faecal sample positive for ST5 by Blastocystis-specific
nested PCR and also established as being positive by
immunoblot (Fig. 1). The negative control sample was
negative by both PCR and immunoblot. In addition, the
proteins were probed with a rabbit anti-Blastocystis poly-
clonal antibody (Rabbit anti-Blastocystis; Antibodies
Incorporated, Davis, CA, USA ) to visualize the Blastocys-
tis proteins in the immunoblot, and the secondary
antibody used was HRP-conjugated polyclonal goat
anti-rabbit immunoglobulins (DAKO, CA, USA). This
demonstrated multiple Blastocystis protein bands ranging
Carpinteria, from 10 kDa to greater than 250 kDa (data
not shown).
Statistical analysis
Statistical analysis was carried out using WINPEPI (17).
This was used to calculate the odds ratio and their lower
and upper 95% confidence intervals between the presence
of different immunoblot bands and (i) different age groups
of pigs, (ii) PCR results and (iii) STs, respectively, using
the Pearsons chi-squared test.
Ethics statement
This project was approved by the University of Queens-
land Animal Ethics Committee with approval nos.
ANRFA/472/11 and ANRFA/SVS/347/12.
RESULTS AND DISCUSSION
Using harvested porcine faecal antibody and goat anti-pig
IgA against WR1 antigen, it was observed that the IgA
reacted with Blastocystis proteins of approximately 175, 37,
50, 120 kDa and >250 kDa molecular weight (Table 1). Of
the 233 pig samples, 190 (815%) were considered immuno-
blot positive, that is having reactivity against one or more
Blastocystis-specific protein bands: each with variable
reactivity in the immunoblot (Fig. 1 and Table 1). There
was no statistically significant difference between the
percentage of immunblot positives between each age group
(sows/boars 885%, growers/weaners 753% and piglets 70%,
v² not significant). In addition, there was no correlation
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Figure 1 Immunoblot demonstrating pig faecal IgA reactivity
specific to Blastocystis antigen. Lane 1 – molecular weight marker
(Bio-Rad), Lane 2 – positive control, Lane 3 – representative
sample from a pig which also has reactivity to a > 250 kDa
protein.
Table 1 Molecular weights and frequencies of antigen bands/
proteins recognized by pig faecal IgA in immunoblot
Total PCR positive PCR-negative
No. of samples
tested
233 164 69
No. of positive
samples (%)
190 (815) 136 (829) 54 (783)
Samples with
175 kDa protein
176 125 51
Samples with 37 and
50 kDa proteina
182 131 51
Samples with
120 kDa protein
167 120 47
Samples with
>250 kDa protein
43 34 9
aReactivity to the 37 kDa band was always found in conjunction
with the 50 kDa.
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between the pattern of immunoblot bands observed and the
infecting ST/s (data not shown).
There was also no statistically significant difference
between age group and percentage immunoblot positives
for IgA reactivity to 175, 37, 50 and 120 kDa protein
bands. However, when considering the faecal IgA reactiv-
ity to the >250 kDa protein band, there was a statistically
greater proportion of immunosuppressed research pigs
(100%) and piglets (500%) with reactivity compared to
the sows/boars (92%) and the growers/weaners (162%),
respectively (Table 2 and 3). The odds ratios demonstrated
that immunosuppressed pigs are much more likely to have
this reactivity compared to the other three groups of pigs
(OR = ∞; Table 3). They also demonstrated that piglets
are 98 and 52 times more likely than the sows/boars and
growers/weaners, respectively, to have this reactivity
(Table 3). Thus, it appears that a less competent immune
system in the experimentally immunosuppressed growers
and piglets may have an influence on faecal IgA reactivity
against the >250 kDa Blastocystis protein band. Possible
reasons for this higher prevalence of IgA reactivity could
be that the lack/deficiency in other components of the
immune system, for example T-cell-mediated immunity,
which leads to compensation with a secretory IgA
response. Alternatively, the immunosuppressed individuals
may have a higher burden of Blastocystis organisms that
colonize multiple intestinal site (small and large intestine),
as was observed in our previous study (4). This might
result in differences in antigen presentation and immune
regulation compared to that of older pigs (18).
To date, there have been two reports identifying possible
immunogenic markers for Blastocystis: (i) a report on
symptomatic patients having significantly higher serum
IgG reactivity against a 29 kDa protein compared to
asymptomatic patients (19) and (ii) a study in Balb/C mice
immunized with Blastocystis in which proteins of 398, 55,
562, 776 and 708 kDa molecular weight were commonly
recognized by either serum or intestinal antibodies (13).
However, this is the first report of a >250 kDa protein
that could potentially be used to investigate pathogenesis.
Future studies should be undertaken to identify this
>250 kDa protein and comparisons made with symptom-
atic patients before further conclusions can be drawn.
Intestinal protozoa have been reported to cause
increased morbidity and mortality in immunocompro-
mised hosts such as immunocompromised children, HIV
patients and transplant patients (18, 20–22). This link
has also been suggested for Blastocystis infections (18,
22–25), with immunocompromised individuals being more
susceptible to infection and more likely to develop clinical
symptoms. Immunosuppression can cause secondary gas-
trointestinal effects such as impaired T-cell-mediated
immune response, loss of gastric acidity and reduced
mucosal integrity (18, 26). Of particular importance is
impaired T-cell-mediated immune response which has been
Table 3 Chi-square analysis of the proportion of pigs in each respective age group with IgA reactivity against the >250 kDa antigenic
protein band
Age group comparison
Pearsons
chi-square
value (v2) P-value Odds ratio (95% CI)
Adultsa vs. intermediateb vs. piglets 29187 0000 N/A
Adults vs. intermediate 2098 0148 053 (95% CI = 022–126)
Piglets vs. adults 28882 0000 983 (95% CI = 349–2756)
Piglets vs. intermediate 12218 0000 518 (95% CI = 178–1518)
Immunosuppressed pigs vs. adults 36041 0000 ∞ (95% CI = 76677–∞)
Immunosuppressed pigs vs. intermediates 19122 0000 ∞ (95% CI = 39544–∞)
Immunosuppressed pigs vs. piglets 4375 0036 ∞ (95% CI = 07544–∞)
vs., versus.
aAdults include sows and boars.
bIntermediate includes growers and weaners, but excludes the five immunosuppressed research grower pigs.
Table 2 Proportion of pigs in each respective age group with IgA
reactivity against the >250 kDa antigenic protein band
Age group
No. of
pigs
No. of positives
for >250 kDa band
(%; 95% CI)
Adultsa 130 12 (92%; 43, 142)
Intermediateb 68 11 (162%; 74, 249)
Immunosuppressed
pigs
5 5 (100%)
Piglets 30 15 (50%; 321, 679)
aAdults include sows and boars.
bIntermediate includes growers and weaners, but excludes the five
immunosuppressed research grower pigs.
506 © 2014 John Wiley & Sons Ltd, Parasite Immunology, 36, 503–508
W. Wang et al. Parasite Immunology
shown to facilitate intestinal protozoa infection in the
immunocompromised host, although the pathogenesis is
unclear (18).
Of 164 Blastocystis PCR-positive samples, 829% were
immunoblot positive for Blastocystis-specific antibodies.
Of 69 PCR-negative samples, 782% were positive for
Blastocystis-specific faecal IgA. The difference is, however,
not statistically significant. Possible explanations for the
PCR-negative and immunoblot-positive pigs are that (i)
absence of infection with Blastocystis at the time of faecal
collection does not rule out previous infection with Blasto-
cystis and therefore pre-existing antibodies and (ii) inter-
mittent shedding of Blastocystis may have resulted in false
PCR-negative results in the single-faecal samples collected
per pig. In the case of PCR-positive but immunoblot-neg-
ative samples, infected pigs may have an absent or insuffi-
cient IgA response that was not detected by
immunoblotting. In addition, we speculate that in this
group of pigs, the immune system components other than
the humoral response are being activated to clear the
infection.
A limitation of this study is that it is qualitative but
only semi-quantitative. The use of other immunological
techniques (e.g. ELISAs) in future studies could provide
better quantification of the immune response. Neverthe-
less, this is the third study to investigate the faecal IgA
response to Blastocystis. The previous two studies were
performed on human stool samples and intestinal secre-
tions from experimentally infected mice, respectively, while
most other studies have been conducted using serum.
Given that Blastocystis is an intestinal protist implicated in
predominantly gastrointestinal symptoms, identifying the
local/direct (i.e. faecal) immune response to Blastocystis
would be paramount to understanding how the intestinal
tract responds to this organism. Our results clearly point
to the pig, particularly immunocompromised pigs, as a
model to explore Blastocystis pathogenesis. The present
results represent a baseline for future studies.
CONCLUSIONS
In conclusion, we have shown that a large proportion of
pigs in conventional herds in Queensland have faecal IgA
specific for at least five Blastocystis proteins. Importantly,
we found that reactivity with a Blastocystis protein of
>250 kDa molecular weight may distinguish animals with
a compromised or immature immune response. It is likely
that additional studies to identify this >250 kDa protein
and the underlying reasons for its almost exclusive immu-
nogenicity in immunodeficient animals will provide impor-
tant information on the pathogenesis of Blastocystis.
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Chapter 6:                                 
Discussion and conclusions 
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6.1 Introduction 
Blastocystis is an enigmatic, intestinal protozoon that commonly infects a wide range of human and 
animal species worldwide (Alfellani et al., 2013b; Alfellani et al., 2013c; Stensvold et al., 2009a; 
Tan, 2008). It was first described in 1911 by Alexeieff (Tan, 2008), and a century later its 
pathogenicity and pathogenesis is still unclear. In recent years, it has been implicated as a potential 
cause of IBS in humans (Boorom et al., 2008; Giacometti et al., 1999; Stark et al., 2007) but this 
has been controversial due to a lack of evidence.Three major obstacles to elucidating the role of 
Blastocystis in human disease have included 1) a poor understanding of the host-parasite 
relationship (i.e. pathogenicity and pathogenesis), 2) diagnostic limitations and 3) importantly, the 
lack of a representative animal model for blastocystosis to fulfil Koch’s postulates (Clark et al., 
2013; Stensvold et al., 2009c; Tan et al., 2010). Experimental infection/pathogenicity studies have 
been conducted in guinea pigs, mice, chickens and rats to date but have reported conflicting and 
inconclusive results. The polymorphic microscopic appearance of Blastocystis organisms has led to 
diagnostic limitations which have likely resulted in both false positive and false negative 
identifications. Furthermore, investigators have often not taken into account the extensive genetic 
diversity of Blastocystis and failed to interpret data in light of genotype / ST, especially with the 
emerging theory of ST dependent pathogenicity of the organism (Stensvold et al., 2009c). In 
addition, use of non-standardised and sometimes insensitive diagnostic techniques, such as light 
microscopy only, and failure to exclude other possible causes of gastrointestinal symptoms in 
patients diagnosed with blastocystosis in some studies has further hindered an understanding of 
pathogenic potential (Clark et al., 2013; Stensvold et al., 2009c; Tan, 2008; Tan et al., 2010).  
 
The principle aim of this project was development of an animal model for blastocystosis that was 
likely to be most representative of human infection. Dogs were chosen as a candidate species based 
on the fact that they are in close daily contact with humans and have previously been proposed as a 
potential zoonotic source of Blastocystis infection to humans (Nagel et al., 2012). Pigs were also 
chosen as a candidate species as there have been widespread reports on Blastocystis carriage in this 
species, including one study demonstrating probable zoonotic transmission of a pig-associated ST, 
ST5, between pigs and humans. Therefore, the suitability of these two species as animal models was 
investigated. 
 
6.1.1  Pigs models to study human disease 
Given the fact that pigs are remarkably similar to humans in terms of anatomy, physiology and 
genetics, they make good representative animal models to study human disease as they show similar 
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clinical signs and susceptibility to human pathogens (Meurens et al., 2012; Zhang et al., 2013). 
These include human infectious gastrointestinal pathogens such as Cryptosporidium parvum, 
rotavirus, norovirus and Helicobacter pylori (Meurens et al., 2012; Zhang et al., 2013). In addition, 
pigs are readily available worldwide, easy to handle, have a long enough lifespan to allow for 
disease development, are omnivorous like humans, have many research tools (e.g. antibodies, 
ELISAs, cell lines, microarrays)  available and are of reasonable size to provide sufficient samples 
(Meurens et al., 2012). In comparison to other animal models, pigs are significantly cheaper than 
non-human primates, that are more closely related to humans, and their physiology is much more 
similar too humans as compared to rodents that do not show similar clinical manifestations 
observed in human gastrointestinal diseases (Meurens et al., 2012; Zhang et al., 2013). It has been 
demonstrated using next generation sequencing that germ free pig intestine can be colonised with 
human faecal microbiome to produce a realistic model of the human gastrointestinal tract (Zhang et 
al., 2013).  
 
6.2 Hypotheses, aims and main findings  
 
Hypothesis 1 (Dog prevalence study):  
 a) If Dogs are natural hosts of Blastocystis, then screening populations using faecal PCR will 
result in one or more ST/s being commonly amplified, presumably the host adapted ST/STs. 
 b) If Dogs harbour (as determined by PCR on faecal samples) similar Blastocystis ST/s to 
humans, they may be zoonotic reservoirs of Blastocystis. 
Aim 1:  Investigate the molecular epidemiology of Blastocystis in pet/pound/stray dogs in three 
different geographic and environmental settings. 
 
In chapter 2, PCR was used to investigate the molecular epidemiology of Blastocystis in pet/ 
pound/stray dogs in SEQ, three cities in India and a rural village in Cambodia using faecal samples 
(Wang et al., 2013). The prevalence of Blastocystis in the Brisbane and Cambodian dogs were 2.5% 
and 1.3%, respectively, in contrast to 24% in the Indian dogs. The Brisbane and Cambodian dogs 
only harboured ST1 and ST2, respectively, whereas the Indian dogs carried a diverse range of STs, 
namely STs 1, 4, 5 and 6 (Wang et al., 2013). The results indicate that there is geographical 
variation in the prevalence and ST distribution of Blastocystis in dogs, as has also been 
demonstrated in humans (Alfellani et al., 2013b). Given the low Blastocystis prevalence and the 
lack of a predominant ST/s, we speculate that dogs are unlikely to be natural hosts of Blastocystis 
but rather, are transiently and opportunistically infected. The high prevalence and greater range of 
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STs observed in the Indian stray dogs, coupled with their ability to be opportunistically infected by 
zoonotic and a range of other STs, does warrant their role as opportunistic zoonotic reservoirs be 
considered in cases where there is close association with humans (Wang et al., 2013). We 
concluded that dogs are unsuitable for animal model development (Wang et al., 2013). 
Subsequently, we decided to investigate the suitability of pigs as animal models based on the 
reasons stated above, by first examining the molecular epidemiology of Blastocystis in this species 
and to explore their potential as zoonotic sources of Blastocystis for in-contact humans. 
 
Hypothesis 2 (Pigs and piggery staff prevalence study): 
 a) If pigs are natural hosts of Blastocystis, then screening populations using faecal PCR 
will result in one or more ST/s being commonly amplified. 
 b) If Pigs harbour similar Blastocystis ST/s to their in-contact humans, then they may be 
zoonotic reservoirs of Blastocystis. 
Aim 2:  Investigate the molecular epidemiology of Blastocystis in pigs and their potential role as 
sources of zoonotic Blastocystis for in-contact humans in two different geographic and 
environmental settings. 
 
In chapter 3, PCR assays were used to investigate the molecular epidemiology of Blastocystis in 
pigs in commercial piggeries in SEQ and semi-domesticated pigs in a rural Cambodian village. The 
prevalence of Blastocystis was 76.7% and 45.2%, respectively, in the SEQ and Cambodian pigs, 
and all positive pigs harboured ST5, presumably the host-adapted ST in both these geographical 
regions (Wang et al., 2014c).  The majority of pig handlers in SEQ harboured STs 1 and/or 3 and 
the Cambodian small holder pig farmers harboured STs 1, 2 or 3 (Wang et al., 2014c), supporting 
earlier findings of some geographical variation in Blastocystis STs among humans (Alfellani et al., 
2013b). Interestingly, a minority (13.9%) of the SEQ piggery staff harboured ST5, which is rarely 
reported in humans, suggesting zoonotic transmission of ST5 from pigs to humans possibly through 
close daily contact with pig faeces. A minority of the pigs also harboured STs 1 and/or ST3 in 
addition to ST5, which could indicate reverse zoonotic transmission (Wang et al., 2014c). Based on 
the above results, we concluded that pigs are likely natural hosts of Blastocystis and are also able to 
harbour STs 1 and/or 3, which are the two most frequently reported STs in humans (Alfellani et al., 
2013b). Given these findings, pigs are proposed as potential animal model candidates, and the 
remaining chapters consist of experiments that further investigate their suitability.  
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Hypothesis 3 (Intestinal study):  If pigs are good candidates for an animal model, then Blastocystis 
organisms will behave as reported in humans. Specifically, they will reside predominantly in the 
large intestine and cause minimal/no pathology in these hosts. ; whereas clinical disease in 
minority of the infected hosts may be associated with other disease causing mechanisms. 
Aim 3: Define the location of Blastocystis ST/s in the pig intestine and identify any organic 
pathology associated with infection.  
 
In chapter 4, we aimed to further characterise the host-parasite interaction in porcines by using 
faecal smears, culture, PCR and histological analysis to localise Blastocystis in the intestine. The 
presence of any histopathology associated with infection was also investigated. Pigs from three 
different management systems were included in the study, namely a commercial piggery, a small 
scale family farm and a dexamethasone-induced immunosuppressed research herd. Blastocystis 
DNA/organisms were primarily identified in the large intestine of all pigs examined, with all pigs 
harbouring ST5 (Wang et al., 2014a). The presence of Blastocystis predominantly in the large 
intestine is in agreement with other animal infectivity and human studies (Fayer et al., 2014; Moe et 
al., 1997; Phillips and Zierdt, 1976; Yoshikawa et al., 2004c). However, Blastocystis was also 
detected in the small intestine of all immunosuppressed pigs and some family farm pigs which 
suggests that immunosuppression and/or husbandry factors may influence Blastocystis colonisation 
of this part of the gastrointestinal tract (Wang et al., 2014a). There was no obvious histopathology 
associated with infections, which also corresponds to findings in the majority of infected humans 
(Wang et al., 2014a). This supports the hypothesis that pig Blastocystis infections closely mimic 
those of humans, with respect to location and histological effects of infection. All pigs examined 
were asymptomatic and it remains a possibility that organic pathology occurs in symptomatic pigs, 
however, it is also possible that Blastocystis causes clinical disease via other mechanisms such as 
immunomodulation, upregulation of inflammatory cytokines (Chandramathi et al., 2010b; Puthia et 
al., 2008) or disruption of intestinal epithelial permeability (Dagci et al., 2002; Puthia et al., 2006). 
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Hypothesis 4 (serological study): If functional immunomodulation rather than organic pathology 
results in Blastocystis associated disease,  then this may be evident in differences in Blastocystis 
specific host IgA immune response according to various factors (e.g. age group, immune status, 
infecting ST). 
 Aim 4: Characterisation of the Blastocystis specific faecal IgA response in pigs, using Western 
blotting, to determine whether reactivity against any particular antigen correlates with age group, 
immune status or infecting ST. 
 
In chapter 5, we aimed to characterise the Blastocystis-specific IgA faecal immune response of SEQ 
pigs of various ages including a subset of the immunosuppressed research herd from the previous 
study. IgA was chosen specifically as it is exported across gastrointestinal mucous membranes and 
most importantly, dominates humoral mucosal immunity (Macpherson et al., 2008). The majority of 
the pigs had a Blastocystis-specific faecal IgA response against Blastocystis proteins of 17.5, 37, 50 
and 120kDa molecular weight. In addition, a minority (18.5%) also had reactivity against a 
>250kDa protein (Wang et al., 2014b). Notably, immunosuppressed pigs, followed by piglets, were 
significantly more likely to have faecal IgA reactivity to this protein as compared to sow/boars and 
growers/weaners, respectively (Wang et al., 2014b). The results suggest that the Blastocystis protein 
of >250kDa molecular weight may distinguish animals with a compromised or immature immune 
response. Further studies are required to identify this protein and determine its potential use as a 
biomarker to investigate pathogenesis.  
 
6.3 Strengths and limitations of the study 
The main strength of this study is the multifaceted approach to investigate Blastocystis infection in 
pigs using microscopic, molecular and immunologic diagnostic techniques. This allowed us to not 
only corroborate, but also to combine, information for a better understanding of the host-parasite 
relationship and therefore facilitate study of pathogenicity/pathogenesis of Blastocystis in pigs. In 
addition, we were able to access a large range of samples, some of which had been collected for 
other projects and subsequently stored. The existence of these stored samples meant that canine and 
porcine samples from multiple geographical locations and environmental settings could be screened 
without the time consuming collection phase. The results of the project were also strengthened by 
access to pigs from different age groups, immunosuppressed research pigs and human samples from 
piggery workers. 
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Shortcomings of the study included the ability to only collect a limited number of faecal samples 
per animal, limited or no access to controls and the fact that only asymptomatic animals were tested. 
The lack of axenic cultures from pigs was an additional shortcoming. These shortcomings will be 
further elaborated by chapter. 
 
In chapters 2 and 3 (dog and pig epidemiological studies) only one faecal sample was obtained per 
animal due to time and financial constraints. This is suboptimal given that intermittent shedding of 
Blastocystis has been reported previously and while a single sample can provide a ’snapshot’ in 
time of infection status, it may not provide the full epidemiological picture (Stensvold et al., 2009c; 
Tan et al., 2010). The relatively small sample size was also of some concern initially. Sample sizes 
of 240 SEQ pigs and 73 Cambodian pigs, allowed the prevalence and 95% CI to be predicted with 
5.4% and 11.4% error, respectively. Sample sizes of 80 Indian stray dogs, 80 Brisbane pet/pound 
dogs and 80 Cambodian village dogs allowed the prevalence and 95% CI to be predicted with 9.6%, 
2.4% and 2.4% error, respectively. Fortunately the differences in prevalence were unequivocal with 
low and high prevalence being found in the dogs and pigs, respectively. The likelihood that each 
species was a natural host could still be determined with confidence despite this shortcoming.  
 
In chapter 4 (intestinal study), as all pigs tested were positive for Blastocystis in one or more 
segments of intestine, there were no animals to serve as an external negative control. Intestinal 
segments that tested negative by microscopy, XIVC and PCR were used as control tissue in the 
absence of an alternative. Despite this, significant organic pathology was not observed, either in the 
positive intestinal segments or control segments; therefore this limitation is unlikely to have major 
impact on the overall results.  
 
As for chapters 2 and 3, chapter 5 (serological study) involved testing of only one faecal sample per 
animal despite recognised intermittent shedding of Blastocystis. All pigs tested were asymptomatic 
to our knowledge, so similar to chapter 4, a comparison with a cohort of symptomatic pigs or 
experimentally infected and symptomatic pigs would have been more appropriate, with a caveat that 
infected pigs are first shown to be able to develop clinical disease. Despite multiple attempts, we 
were unable to obtain an axenic Blastocystis culture from pigs which would have been ideal for this 
study considering that we were testing for the porcine faecal IgA immune response. Instead, we 
used an axenic culture, WR1, which was originally obtained from a rat (Chen et al., 1997). This 
should be pursued in future studies. 
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For both chapters 4 and 5, only asymptomatic pigs were examined. Comparison with a cohort of 
infected and symptomatic pigs would have been appropriate; however, we are yet to determine if 
Blastocystis can cause clinical signs/disease in pigs. It is widely recognised that though Blastocystis 
infection is common in humans, only a minority of infected people appear symptomatic, and 
whether infected pigs can develop clinical disease is yet to be investigated. If pigs can develop 
clinical disease, then comparison between symptomatic and asymptomatic pigs would be 
worthwhile in the future. Regular monitoring of the immune system (e.g. ELISAs, Western 
blotting) of the dexamethasone-treated pigs to determine specific changes or differences from the 
healthy pigs would have helped further strengthened the possible link between immunosuppression 
and blastocystosis. To further reduce confounding aspects, the study would have benefited from 
controls consisting of gnotobiotic piglets, Blastocystis-positive healthy pigs and immunosuppressed 
pigs raised under the same husbandry conditions (e.g. housing, diet, antibiotic regime).  
 
6.4 Future directions 
To date, our results indicate that Blastocystis infection in pigs is similar to that reported in humans 
in regards to the predominant localisation of Blastocystis in the large intestine and the lack of 
significant organic pathology associated with infection. Moreover, we have demonstrated that pigs 
are able to harbour STs in common with humans, namely STs 1 and 3. Corroborating these results 
with previous pig and human studies, we propose that pigs are likely to be a suitable animal model 
for studying the pathogenesis/pathogenicity of Blastocystis in humans. Further characterisation of 
the host-parasite relationship is required before drawing conclusions, and some of these areas for 
future research are discussed. 
 
6.4.1 Utilising multilocus sequence typing (MLST) to study the transmission dynamics of 
STs 1, 3 and 5 between pigs and humans. 
In chapter 3, MLST was not used to accurately determine if there was in fact zoonotic transmission 
of ST5 from pigs to humans and reverse zoonotic transmission of STs 1 and 3 from humans to pigs. 
Due to financial constraints, MLST for ST3 was not performed, while MLST for STs 1 and 5 are 
currently not available. Based on an MLST study of numerous ST3 isolates, Stensvold et al. 
(2012b) reported substantial intra-ST genetic diversity within ST3. They also suggested that there is 
high host specificity within ST3 and that human ST3 isolates that fall into a certain category (i.e. 
mitochondrion-like organelle Clades 2 to 4) are most likely due to zoonotic transmission. The use of 
these MLST systems for ST3 could have been used in our study to determine if the ST3 isolates 
obtained from the pigs and humans are identical or highly similar, and whether or not zoonotic or 
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reverse zoonotic transmission has occurred. Similarly, future work should involve development of 
ST1 and ST5 MLST systems to analyse the isolates obtained from SEQ pigs and piggery staff to 
determine whether reverse/zoonotic transmission has occurred. If this was the case, it would 
reinforce the fact that pigs are able to harbour identical ST isolates as humans and vice versa. 
 
6.4.2 Obtaining axenic cultures from pigs and/or symptomatic humans for animal infectivity 
studies and in vitro studies 
Despite the fact that obtaining axenic Blastocystis cultures is a notoriously time consuming and 
labour intensive process, it has been achieved in a few laboratories (Lanuza et al., 1997; Ng and 
Tan, 1999). Axenic cultures of STs 1, 3 and/or 5 from pigs or any isolate from symptomatic humans 
would be of great value for in vitro studies as well as experimental infections in pigs. 
 
6.4.2.1 In vitro studies 
Axenic Blastocystis cultures could be used in in vitro studies to infect human and/or porcine colonic 
epithelial cells for use in studying various aspects of infection such as method of epithelial cell 
invasion, cytopathic effects and cytokine responses. Protein could also be extracted from these 
isolates and analysed using immunological techniques such as Western blotting and ELISAs to 
qualify, quantify and compare the immune responses from both faeces and serum of 
symptomatic/asymptomatic pigs and humans. Comparisons could be made between the different 
STs and isolates to determine if there was inter-ST variability of immune responses. Lastly, other 
diagnostic reagents such as monoclonal antibodies could be developed based on these axenic 
cultures.  
 
In combination, antigen and monoclonal antibodies could lead to identification of biomarkers to 
predict clinical outcomes and be used for development of diagnostic tests and treatment options.  
 
6.4.2.2 Experimental infections 
Axenic cultures from pigs and symptomatic humans could be used to infect naïve piglets, 
dexamethasone-induced immunosuppressed pigs and control pigs, or pigs infected with other 
intestinal pathogens so as to study various aspects of the infection such as: 
1. Whether they become infected and show clinical signs (nature and range)? 
2. Which section of the intestine is predominantly infected? 
3. Whether they develop organic pathology? If so, at which location? 
4. Whether they have a specific faecal or systemic immune response? 
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5. The effect of co-infections on the overall disease spectrum and outcome 
These results, especially from infection with symptomatic human isolates, could be used for 
comparison with results obtained from naturally infected pigs in order to determine if any of these 
factors contribute to pathogenesis/pathogenicity or development of clinical disease, if any. 
 
6.5 Conclusions 
In conclusion, this study has shown that pigs and not dogs are potential animal models for the study 
of human blastocystosis by determining that: 1) pigs are likely to be natural hosts of Blastocystis as 
they have a high prevalence of Blastocystis, with the majority harbouring ST5, presumably their 
host-adapted ST, 2) they are able to harbour STs 1 and/or 3, which are the two most common STs 
reported in humans, 3) Blastocystis organisms reside mainly in the porcine large intestine without 
causing any obvious organic pathology, similar to what is reported in the majority of humans 
examined. We also demonstrated that ST5 in pigs could have zoonotic potential and that constant 
close contact between pigs and their human handlers under intensive conditions increases the risk of 
transmission. A possible link between Blastocystis carriage and immunosuppression, also suggested 
by previous studies, was supported by our results in that immunosuppressed pigs appeared much 
more likely than healthy pigs to harbour Blastocystis organisms in their small intestine. In addition, 
piglets and immunosuppressed pigs are also much more likely than healthy older pigs to have a 
faecal IgA reactivity to a >250kDa Blastocystis protein, though the implications of both these 
aspects need to be further investigated. Overall, our results suggest that pigs may be an ideal animal 
model for studying human blastocystosis and future studies with proper controls are required to 
further investigate the host-parasite relationship before determining the pathogenicity/pathogenesis 
of the organisms. 
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